Introduction: A 2011 survey in our department showed that allogeneic stem cell transplant (SCT) patient's compliance to oral therapies is not optimal. In fact, not all of them know the indication or the number of daily intakes for each drug. Some of them think the information received from the staff is not enough, and others say they regularly miss doses of Cyclosporine. Goals: In order to improve patient's observance to their oral treatments, we implemented a therapeutic education program (TEP) for the SCT recipients. The primary objective was to increase patient's understanding and knowledge of his treatments and therefore his compliance to the medical prescription. Methods: Our program consists on improving the information we provide to SCT patients about their oral treatments. Therefore, a nurse working group designed a patient's booklet that summarizes indications, possible side eff ects, precautions, intake modalities and tips for the 10 main oral therapies prescribed after SCT in our unit: cyclosporine, steroids. The booklet helps the patient remember at home the information and advice given to him. It is also an educational support for the nursing staff . Giving that half of the nurse staff renewed over the past year, we organized training courses for all nurses about those oral therapies. Henceforth, in addition to the guidelines given to the patient by the medical team, nurses can give him all the information and advice he needs, and help him understand better the importance of each oral treatment and the risks of missing doses. This becomes a formalized paramedical check-out consultation as required in the national cancer program [2009] [2010] [2011] [2012] [2013] . Results: Before the SCT patient returns home a paramedical check-out consultation is organized: it's a formal and documented teaching moment between the nurse and the patient. It helps caregivers to formulate therapy in a targeted manner, sensitizing the patient and thus overcome his lack of knowledge and bring about an improvement to his adherence. Conclusion: Non-adherence to medication intake after SCT may compromise the results of transplant. Leaving the transplant unit is always a stressful moment for SCT patients. The TEP we implemented in our department helps patients soothe their worries and learn more about their treatments. Later on, a nurse followup consultation will maintain the educational continuity. Whether this program improves the results of transplant should be prospectively evaluated.
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The KFSH&RC (Saudi Arabia) Stem Cell Donor Registry experience R. Belkhedim King Faisal Specialist Hospital & Research Center (Riyadh, SA) The HSCT Program at King Faisal Specialist Hospital and Research Centre (KFSH&RC) has been operating since 1984. By the end of 2011, more than 3,000 allogeneic and almost 900 autologous cases were successfully performed. Studies established that eff ective application of HSCT requires suitable patient selection, treatment protocols and healthy source of hematopoietic stem cells. The optimal hematopoietic stem cell source is from an HLA matched sibling. HSCT from HLA identical siblings, signifi cantly reduces the risk of transplant related morbidity and mortality and improves outcome. Initial testing of siblings and parents of patients in need of HSCT is used to identify an HLA matched sibling, as the probability of fi nding a matched sibling is 65%. However, for patients who do not have HLA identical sibling, unrelated donors can be used as the next best option. In Saudi Arabia, a functional unrelated bone marrow registry is lacking. A well matched unrelated adult donor (URD) can just be sought from nearly 14 million donors registered and HLA-typed by the US National Marrow Donor Program ® (NMDP) and other collaborating registries. However, the extreme polymorphism of the HLA alleles within the relevant major Histocompatibility Complex (MHC) loci limits the success in identifying an allelematched donor. In our experience at KFSH&RC HSCT programs, the chance of fi nding an HLA matched donor from the major international registries is less than 10%. In eff ort to improve alternative donor availability, KFSH&RC established an institutional cord blood bank in the year 2008 that provides cord blood units for transplantation programs in the whole country. As one of the world's leading transplant programs, KFSH&RC will continue its commitment in serving patients with the world class quality of care services. Therefore, the next important step is to establish unrelated donor registry that aims to improve alternative unrelated donor availability, not only for Saudi patient population but also for the whole region with its unique HLA phenotype at much less cost. The benefi ts of this registry will include:
• Availability of suitable donors from the Saudi population with similar ethnic group.
• Improve KFSH&RC collaboration with other international donor registries.
• Cost eff ective measures in regards of donor's work up costs, harvested stem cell cost and courier traveling expenses.
• Serve emerging stem cell transplant centers within Saudi Arabia and Middle East region P1329 Searching for unrelated haematopoietic stem cell transplant donors within the Brazilian Donor Registry: experience of the bone marrow transplantation unit of Sirio Libanes Hospital (Sao Paulo, Brazil) S. Ferreira, C. Arrais, L. Tucunduva, R. Santos, Y. Novis, V. Rocha Hospital Sirio Libanes (Sao Paulo, BR) Search for unrelated donors (UD) for hematopoietic stem cell transplantation (HSCT) in Brazil is performed by REDOME (Registro de Doadores de Medula Óssea), a department of the governmental institution INCA (Instituto Nacional do Cancer). At HSCT indication patient data including high resolution (HR) HLA typing must be entered in the national recipient registry (REREME). For patients without a HLA identical familiar donor search for UD is initiated by REDOME with low/intermediate HLA resolution typing, followed by HR typing. When one or more donor are identifi ed transplant center will ask for the confi rmatory HLA typing (CT). Once donor is chosen REDOME is responsible for contacting the collecting center for request and shipment of HSC. Sirio Libanes (HSL) is a private hospital in Sao Paulo recognized for the experience in care of oncology patients. HSL's new Bone marrow transplantation unit (BMTU) was opened in 10/2011 and accounts with a multi-professional staff to improve and centralize the care of patients in need of a HSCT, including a designated search coordinator for UD. The aim of this study is to verify differences in number of UHSCT performed in HSL before and after opening a new BMTU, as well as the time from UD identifi cation and transplant. From 08/2010 to 07/2011 (before new BMTU opening) 18 patients were registered in REREME and 4 UHSCT were performed. Median time from CT request and result was 39 days (15 -157) and 18 days (12-5), from graft request and shipment resulting in a median time of 51 days (30-159) from identifi cation of UD to transplant infusion. From 08/2011 to 10/2012 (after new BMTU opening) 47 patients were registered in REREME and 13 UHSCT were performed. A nurse was hired to perform the searches. The median time from CT request and result was 25 days (4-71) and 18 days (7 -53) from graft request to shipment resulting in a median time of 79 days (29-275) from identifi cation of UD to transplant infusion. One patient had HSCT delayed because of 3 potential identifi ed donor's refusal followed by disease relapse. With new BMTU the number of registrations in REREME and UHSCT performed in HSL were increased. The time to obtain results of CT was reduced, but not the time from identifi cation of UD to HSCT, what can be related to the urgency to perform HSCT. In conclusion, a search nurse coordinator is needed in a BMTU in order to speed up the search process and facilitate the contact with Brazilian registry, HLA lab and patients.
P1330
Integration of concepts and methods of CMA in EBP: impact of the multicultural context on patients' adherence to the therapeutic project P. Crombez, S. Michiels, D. Bron Jules Bordet (Brussels, BE) Background: Biomedicine should be understood as issued from the culture by which it is organised, the occidental medical culture based on the application of Evidence Based Practice ("EBP-combination of research based evidence, clinical expertise and patient's preferences and values") but mostly focused on the disease neglecting a more holistic approach. The implementation of concepts and methods of Clinical Medical Anthropology (CMA) and tools of cultural competence can ensure the fully application of EBP and guarantee more patient centred care, including patient's preferences in daily practice. In an oncology multicultural context, diff erences of language and culture between patients and health care providers can decrease adherence to treatment. Objective: To demonstrate the necessity to integrate concepts and methods of CMA in all 3 dimensions of EBP in order to improve adherence to the therapeutic project. Method: We operate a major review of the literature regarding to adherence to the therapeutic project in oncology and in the transplant setting, searching for any correlation with multicultural context. Results: There is poor literature regarding to adherence to therapeutic project in oncology, especially within the transplant setting. Furthermore most studies only include small population of patients, don't explore the prevalence of non-adherence, and are limited to medication adherence neglecting the entire therapeutic project. Finally, the literature explores mainly the socioeconomic factors but none potential correlation with the multicultural context. Conclusion: Despite the increased use of oral therapies in oncology and during the post transplant period, we observed a lack of research concerning the correlation between the multicultural aspects and adherence to therapeutic project in daily practice. Nevertheless CMA as science with his concepts of illnesssickness-disease contributes to understand the intercultural nature of medical consultation and his potential impact on adherence to treatment. Ensuring the development of cultural competence (knowledge, attitudes, and behaviours) of health care providers and institutions can off er more effi cient care, particularly in a multicultural practice. Consequently there is a need to explore these issues more in depth by quantitative as well as qualitative research. Integrate CMA in EBP should permit both to fully implement the 3 dimensions of EBP and to establish this valid large scale research. A. Mohamad King Faisal Hospital (Riyadh, SA) Terminally ill patients and their families are a vulnerable group that needs specialized, culturally and religiously sensitive care. Their physical, psychological and spiritual needs have to be addressed in a way that is based on knowledge and understanding of their social and religious background. Spiritual care is one of the integral components of comprehensive palliative care directed to care for terminally ill patients and their families. It is important for healthcare practitioners to understand the religious and social background of their patients. There are few articles in the literature to guide health care professionals in specifi c requirements for care of the terminally ill Muslim patients. Understanding such requirements will help in the delivery of quality healthcare to Muslim patients and their families. In addition, it aids in promoting health professionals' awareness of the religious back ground and understanding their Muslim patients' behavior during illness. Knowledge of the religious beliefs will greatly aid in improving communication and decrease the potential confl ict between health care practitioners and terminally ill patients and their families. Islam is one of the major religions in the world. It is regarded by Muslims as religion as well as a way of life. Illness and death is perceived by Muslims as a divine predestination and attributed to the will of Allah (God) . However, Muslims also strongly believe in seeking treatment when they fall sick as guided by religion; "when Allah sends down illness, treatment is sent down at the same time, except for death". Islam considers life as sacred and body and soul belong to God. Death in Islam is defi ned as the departure of the soul from the body and Muslims consider death as cessation of all bodily functions. In this presentation, the presenter aims at highlighting some of the religious and spiritual aspects pertinent to the caring of terminally ill Muslim patients and their families, explores behavior of a terminally ill patient and explains the religious based rational for that behavior and explains rituals surrounding the death of a Muslim patient and the family's reaction during this time. Finally, the presenter briefl y outlines the future of palliative care in the Islamic world in regards to the medical and technical resources allocated to such service.
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Palliative care in paediatric oncology. ADINO Programme E. Trigoso Hospital Universitario y Politecnico "LA FE" (Valencia, ES) "WHO (World Health Organization) defi ned the Palliative care for children as the active total care of the child's body, mind and spirit, as well as giving support to the family which is absolutely essential. It begins when illness is diagnosed, and continues regardless of whether or not a child receives treatment directed at the disease. It can be provided in tertiary care facilities, in community health centers and even in children's homes". The purpose of this papers is to describe the ADINO program which is the Home Care unit for Oncologic Children dependent from the Oncologic Pediatric Unit which began working in April 1997. The team is composed of: 1 Pediatric Oncologist, 4 Nurses, 1 Data manager-all of them have experience in Pediatric Oncology and Palliative Care. The service is provided 24 hours a day, 365 days a year. The coverage area is Comunidad Valenciana with: 23.555 km 2 and 5.5 million inhabitants. The design of this study has been a descriptive and retrospective study. The population of the study has been: All pediatric cancer patients admitted to the Pediatric oncology unit of the Hospital Universitario y Polytechnic "La Fe" in palliative treatment between 1997 and 2011. 109 children in the terminal phase of their diseases have been attended. Males: 58 and females 51. Patient´s median age is 9.7 years old. Median duration of the assistance per child was 56 days. The variables studied were: demographic, diagnosis, duration of the assistance, symptoms control, unscheduled admissions, transfusions, visits, telephone calls, death locations.
S478
Discussion: This program was allowed to include the family home among the therapeutic places available for the palliative treatment of children with cancer. Facilitates appropriate for clinical management, regardless of place of residence. The number of unscheduled hospitalizations is signifi cantly low. This program has been well accepted by our patients and their parents. A high degree of satisfaction has been shown which permits them to shorten their stay in the hospital and allows if not fosters the maintenance of family dynamics, along with the preservation of privacy and the involvement of family members parents and brothers in the care of the sick child.
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A prospective study on the characteristics of fever and urticaria following administration of ATG in the BMT unit: a nursing initiative towards improved patient education Z. Al Harthy, C. Lagar, J. Goes, S. Wilson, A. Juanitas, E. Gallardo, J. Thomas, B. Mathew, Y. Al Habsi, S. Simon, C. Trampe, C. Biniza, J. John, D. Mathew, M. Mathew, R. Kunjan, I. Al Manthari, V. Recto, R. Varghese, K. Al Salimi, S. Jose, S. George, J. John, R. Al Mahrizi Sultan Qaboos University Hospital (Muscat, OM) Anti-thymocyte globulin (ATG) is an integral part of many transplant conditioning regimens for its immunosuppressive role in minimizing graft versus host disease and transplant related morbidity. As fever and urticaria can occur after ATG infusion, it important for the transplant nurse to be familiar with the details of these side eff ects especially within the local patient population. With this in mind the BMT nursing group undertook a prospective study to investigate and document the onset of fever and urticaria in our patients. The short-term specifi c objectives were to characterize the nature and onset of fever and urticaria in this patient population. In the long term this data would be used by the nurses to more eff ectively counsel our patients on these side eff ects. Between January 2010 and September 2012 thirty eight consecutive patients underwent BMT in this center with ATG as part of the conditioning. All patients received rabbit ATG (Fresenius) at a dose of 10mg/kg/day for four consecutive days ending on day minus one. The protocol involved an intra-dermal test dose of diluted ATG on the fi rst day. If there was no reaction, prophylactic administration of methylprednisolone, chlorpheneramine and paracetamol was then given followed by the infusion of ATG in saline over eight hours. The median age was 12 years and ranged from 0.2yrs to 45yrs. Transplant indications were primary immunodefi ciency (34%), hemoglobinopathies (34%), bone marrow failure and paroxysmal nocturnal hemoglobinuria (20%) and leukemia (12%). The incidence of fever and urticaria following ATG was 89% and 40% respectively. The majority of patients who developed fever did so on the fi rst day of ATG while for urticaria there were several patients whose onset was on the second and third days. Most episodes of fever completely resolved on the fi rst day itself. In approximately one third of patients urticaria resolved on the fourth day of ATG (Table 1) . This data will assist the transplant nurse to provide more eff ective counseling and to be able to confi dently reassure patients who are on ATG therapy.
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Patient and parent education in a paediatric autologous stem cell transplant unit A. Da Gloria, C. Rodrigues, S. Lalioui, P. Usubelli, D. Valteau-Couanet, C. Dufour Institut Gustave Roussy (Villejuif, FR) Introduction: At Gustave Roussy Institute, all patients received high-dose chemotherapy (HDCT) followed by autologous stem cell transplantation (ASCT) in protective isolation. The medical and nursing information is essential to prepare and guide the patient and his parents in the plan of care. Objectives: The primary aim to this study was to describe the diff erent methods to provide information about HDCT with ASCT and their side eff ects to patient and his family. The second objective was to evaluate the quality of the received information in parents. Methods: Between January 2012 and October 2012, 70 courses of HDCT with ASCT were performed in 37 patients. Before the treatment, a medical and nursing consultation were planned. Nurses provided information about care and hygiene measures in the protective isolation. Nurses with an ad-hoc questionnaire evaluated patient and parent education. At the discharge, a nursing consultation was performed. Results: All patients received a medical and nursing consultation before HDCT with ASCT. Patient and parents were informed how administer HDCT and ASCT, possible side eff ects and the procedures surrounding day care at the hospital. All information that was provided orally, was draw on a fi gure to the parents and written to the patients' record. At the admission in the protective isolation, nurses provided information about oral care, feeding and general hygiene rules adopted during the hospitalisation. Questionnaire was completed by nurses for all patients. Conclusions: The various methods used by diff erent partners to provide information improve the partnership with patient and parent in the care. In the future, it would be signifi cant to assess how parents evaluate the quality of the received information.
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Multiple adenovirus infections on a paediatric HSCT ward: outbreak or individual infections?
A. Zelenka, S. Wieczorek, S. Matthes, C. Peters, W. Holter St. Anna Children's Hospital (Vienna, AT) Adenovirus (ADV) is one of the major causes of severe infectious complications after haematopoetic stem cell transplantation (HSCT) with limited treatment options. We therefore routinely perform stool screening -and if indicated blood screening -in all our HSCT recipients by PCR-techniques. Furthermore, strict hygiene measures are part of our prevention program. Inpatients who are asymptomatic for ADV-disease are carefully monitored, symptomatic patients undergo protective isolation and in addition we try to identify the infection origin. Here we report on two consecutive episodes of multiple ADV infections. In November 2011 3 patients were simultaneously testing positive for ADV-C2 in stool, one of them with concomitant ADV viremia. The detection of ADV C2 DNA with smear tests from the surrounding, however, did not reveal any contamination. In March 2012 ADV-C infection was detected in another 7 patients. In consequence we performed an internal audit including cleaning and disinfection devices, the effi cacy and the correct application time of the hand disinfection fl uids. In order to prove or exclude an outbreak, we performed ADV typing and ADV was cultivated from patient stool samples. Results: All machines functioned properly and the hand disinfection measures were adjusted to the new producer's recommendation. By typing 3 ADV-C2-strains and 1 ADV-C5-strain were identifi ed. In 3 patients the results were not verifi ed. The isolation of cultured ADV was successful, also with low viral load, so that enough viral DNA is available for sequencing. However, as the typing results showed that a patient-to patient transmission was unlikely, we did not perform the sequencing. Conclusion: The diff erentiation in hygiene measures between symptomatic and asymptomatic patients is useful. With the current hygiene measures a patient-to patient transmission is successfully prevented. The accumulation of ADV-positive patients was more likely due to multiple simultaneous endogenous reactivations than to an outbreak. In case of a suspected outbreak ADV should be typed and in case of identical strains sequencing should be performed to identify the possible infectious origin
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Comparison of axillary, tympanic and standard rectal temperature in haematologic patients; the results! M. M.M. Hollenberg, W. van den Ancker, O. Visser, P.C. Huijgens VU University Medical Center (Amsterdam, NL) Introduction: In hematologic patients, measurement of temperature is crucial to determine whether a patient is suff ering from increased temperature and thus is candidate for antibiotic treatment. At risk for bleeding or infection, temperature is standard measured axillary. It is known that axillary and tympanic temperature is generally lower compared to rectal temperature, which is considered the golden standard. In this study we compared the axillary and tympanic temperature in patients with the rectal temperature. Methods: After obtaining informed consent from patients [n=48], tympanic, axillary and rectal temperature were measured. All patients were admitted to the hospital at time of temperature measurement or received (chemo)therapy in the outpatient department. A total of 232 tympanic and axillary temperature measurements were obtained in 56 patients. Rectal temperature could be measured 139 times. In 13 patients, 3 to 10 times axillary, tympanic and rectal temperature was measured at various time points divided over fi ve subsequent days. Results: Mean tympanic temperature (of both ears) was 0.30 degrees (°C) higher than rectal temperature (n=139 in 48 patients, paired T-test: p<0,0001). For the mean axillary (left and right axillary temperature) temperature, a signifi cant lower temperature was found compared with rectal temperature 0.85°C (n=139 in 48 patients, p<0.0001). In those patients where temperature was measured 5 times or more diff erences were between axillary, tympanic and rectal temperature were sustained within the same patient. However, ratios of axillary/rectal and tympanic/rectal temperatures diff ered signifi cantly between patients. Therefore, the tympanic-rectal temperature diff erence of 0,3°C cannot be applied for every patient. Interestingly the temperature diff erence measured in the left and right ear varied form -0.9°C to +0.8°C Even more, temperature measured in the right ear was signifi cantly higher than temperature measured in the left ear (diff erence 0.06°C paired t-test p<0.01). Conclusions: In patients with contraindications for rectal temperature measurement, consensus is needed for the correct and save temperature measurement. Due to variation of temperature diff erence between rectal and axillary or tympanic temperature in our study, the cut level for fever cannot straightforwardly be applied for axillary or tympanic measured temperatures.
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BK virus-associated haemorrhagic cystitis: diffi culties of the caregivers O. Samsonova, K. Camus, C. Cellard-Béal, C. Dugrenier, L. Gilis, S. Ducastelle, M. Detrait, F. Nicolini, M. Sobh, M. Michallet Lyon Sud Hospital (Pierre Benite, FR) BK virus-associated hemorrhagic cystitis (BK-HC) is a concerning complication that can occur after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Its incidence can reach 16% in unrelated transplantations and 40% in case of umbilical cord blood transplantations. With a mortality linked rate of 4%, this complication has a signifi cant impact on patients quality of life, on their physical and psychological well being, in addition to a longer duration of hospitalisation which causes an economical concern. Its management remains diffi cult and long despite its rapid diagnosis and initiation of conventional treatment (maintenance of normal platelets level by transfusion, bladder washings, analgesics, antispasmodics and Vistide ® administration with increased renal monitoring). As caregivers, we have diff erent experiences towards this complication. The unpredictable pain, intense and of multifactor etiology is diffi cult to curb. In fact, we see our powerlessness facing the pain caused by spasms due to bladder bleeding. Each nurse assesses the clinical situation according to her feelings and experience.
The objective of this study is to gather data on medical and paramedical care of BK-HC, to create a common protocol to standardize care practices within the three hematology departments at our Hospital. The aim is to reduce the BK-HC related complications. Methods: Our actual qualitative study joined the retrospective study performed by the medical staff at our hospital on risk factors and impact of BK-HC in patients who received allo-HSCT between 2007 and 2011 as well as results from 5 other European centers. We also carried out the establishment of a partnership between the medical and paramedical hematologists and urologists on improving practices in early detection (titration and regular monitoring of BK virus), ultrasound monitoring (using portable equipment at bedside with regular bladder check-up), better assessment and management of pain, common consensus on bladder washings. This work has allowed each caregiver to expand its knowledge on the BK-HC. Standardization of care practices shows short-term coherence and consistency in the management, monitoring and evaluation. A survey on the management of the BK-HC related pain is planned for 2014 to study the eff ectiveness our actual protocol. Objectives: To develop an education resource to suit the needs of healthcare professionals caring for Lymphoma Patients. Process: The Lymphoma Nurse Board members were identifi ed as key in the generation of content to be delivered to healthcare professionals, as they possess knowledge of the current clinical requirements for nursing lymphoma patients and staff education issues. Using the nominal group technique (NGT), the group generated an action plan which identifi ed the healthcare professionals to target; ways in which the education could be facilitated and fi nally a priority was identifi ed to take forward. Further to this work an online and paper based survey was issued to the wider nursing forum members to generate a consensus opinion. Results: The fi nal action plan identifi ed that an online resource for the nursing members of the Lymphoma Association forum would allow an increase in their professional education, with the ultimate facilitation of the online resource as a cascade of education to all levels of staff within their local areas. The education will focus on core standards of care specifi c to lymphoma patients and will initially replicate the existing paper based resource. The online platform will give the opportunity to increasingly build a resource that will include case studies, interactive activities and will provide continuous professional development to enhance the healthcare professionals learning portfolios. Conclusion: This presentation will illuminate the inclusive development of an online resource and showcase the fi nal education package.
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Nurse practitioner-led survivorship care: a model of care for the changing needs of allograft survivors Y. Panek-Hudson Peter MacCallum Cancer Centre (Melbourne, AU) There are an increasing number of long term survivors post allogeneic bone marrow transplant. Emerging data and experience suggest that survivors have a higher risk of developing chronic health sequalae as a result of their transplant and pre transplant therapies. In addition the impact of chronic graft versus host S480 disease manifests physically and psycho-socially for many years, depending on organ involvement and severity, and requires close attention and specialised management. The Peter MacCallum Cancer Centre (PMCC) in Melbourne, Australia is the only dedicated cancer centre in Australia. A nurse practitioner (NP) led model of care was developed three years ago for the care of early and late survivors post allograft. This care is provided collaboratively with a multi disciplinary team. The NP led service was developed after the identifi cation of a gap in clinical resources, and a commitment to providing timely assessment, early identifi cation and management of issues, and continuity of care. This presentation will discuss the successful genesis, implementation and growth of this innovative, patient centred model of nurse practitioner led survivorship care.
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Single centre experience of holistic needs tool for service improvement for transplant patients D. Cave, C. Lim Kings College NHS Foundation Trust (London, GB) Introduction: A new holistic tool for clinical nurse specialists was introduced across the cancer network in 2012. The study was interested to fi nd if there were any defi ning correlations found for stem cell transplant patients pre admissions which could help lead to service development within the department to improve patient care. Method: As part of the pre transplant nurse consultation patients, were given the holistic needs assessment and asked to fi ll out. The questionnaire looked at fi ve areas; practical, emotional, spiritual, physical and family concerns. These were looked at by the Clinical nurse specialists and up to four areas were identifi ed where the patients needed help. Over a 9 month period within our team we managed to successfully complete 65 assessments. Results: Of the assessments 65 assessment 60 fi lled the questionnaires out Through the 60 Assessments 42 were found to have practical concerns predominately transport and parking at the hospital and housing and fi nancial issues. 4 were found to have family concerns; in particular relationship with others and their children. 34 were found to have emotional; specifi cally loneliness and isolation, diffi culty making plans, worry/fear and anxiety, sadness and depression. 2 were found to have spiritual concerns resulting in a loss of faith. 34 were found to have physical concerns where it appears more wide ranging. In terms of their appearance, fatigue, dry mouth, taste changes, eating, high temperatures and sleep. 18 when answering said they did not have any concerns. Conclusion: One of the restraining factors found when collecting data, was appropriate private space in order to undertake assessments. The goal is that all patients holistic assessments to be electronically stored and a continuing assessments to take place and service improvements made. Patients to be referred to newly appointed Haematology psychologist.
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Single centre experience of stem cell harvesting regime: results for second autologous transplants in mutiple myeloma patients D. Cave, C. Lim, E. Tatam Kings College NHS Foundation Trust (London, GB) Introduction: During a one year period between September 2011 and September 2012 we had a number of Mutiple Myeloma patients who needed to undergo a second transplant following relapse of their disease. It became evident that there were a number of patients in diff erent clinical trials and diff erent mobilisations being used. Method: A respective qualitative collection of data occurred, looking at the regime used and the harvest results obtained. We were interested to see if there was any correlation. The study looked at 9 individual patients, 2 females and 7 males. The initial cd34, and white cell cell counts and also the end count. The age range was 48-69 years with a mean age of 59. Our centre in accordance with dictates that 2x10 6 is required in order to undertake admission for a High dose melphlan autograft. Cyclophosamide GCSF mobilisation regime due for harvesting on day 10. Double GCSF regime due for harvesting On day 5. Results: Out of the 9 individuals, 2 did not mobilise at all to warrant collecting any stem cells on the allocated days of their harvest. Making a failure rate of 22%. For the fi rst harvest for patients Cyclophosamide GCSF was used in 7 out of 9 of the patients, one GCSF mobilisation, and one Ara-C mobilisation. For the second time harvests 5 out of 9 used Cyclophosmide GCSF Two used double GCSF Two single used GCSF. From the study 7 out of 9 used mobzibil (plexifour) just in time for their second harvests. In the fi rst harvest only 1 out of 9 used mobzibil. The mean amount of days needed to collect for fi rst harvests 1.3 days. The mean amount of days needed to collect for second transplant 2.55 days. The average cd 34 count for 10 6 for fi rst transplant in this patient group was 4.96 to infuse. The average cd34 count for 10 6 for second transplant is 3.05 to infuse. More specifi cally with Cyclophosamide G harvest 2.06 x 10 6 for second time transplants. Compared with GCSF 2.77 x 10 6 Average days 2.4 with Cyclophosamide mobilisation Average days 2.0 with GCSF mobilisation Conclusion: A number of conclusions from the study When making requests for harvesting slots for second transplants, these will always fall on a Monday to allow the maximum fi ve days to collect stem cells. Anyone under the age of 60 when harvesting for the fi rst time will collect enough for two transplants. Further analysis is being undertaken to decide which mobilisation regime should be used for fi rst and second time harvests for a uniformed approach.
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Observational study on the use of Orasol oral solution for mucositis prophylaxis in patients aff ected by lymphoma and multiple myeloma undergoing haematopoietic stem cell transplantation (HSCT) following a melphalan-containing conditioning regimen F. Mariano, L. Orlando, A. Babic European Institute of Oncology (Milan, IT) Background: Melphalan is a chemotherapeutic drug which will likely damage oral mucosa; melphalan containing conditioning regimens are usually administered in patients aff ected by lymphoma and multiple myeloma (Melphalan HD, FEAM). One of the most common complication of HSC transplant is oral mucositis (OM) which can cause pain, negatively aff ect nutrition, communication, deglutition, all symptoms that can prolong hospitalization. In our unit we usually use Benzidamine oral solution for mucositis prophylaxis. In case of intolerance, we use bicarbonate+lidocaine instead. Orasol is a nutrition supplement vegetal based made of Ialuronic Acid and Tabebuia Avellanedae, with antinfl ammatory, analgesic and antifungal activity. The solution does not contain alcool and can be swallowed, allowing patient compliance with activity on esophageal mucosa too. Aims: Evaluating Orasol effi cacy in OM prophylaxis in patients undergoing autologous HSCT following Melphalan containing conditioning regimen. Methods: When patients were admitted to the hospital we illustrated Orasol characteristics and administration modalities (3 mouth washes/day: keep the solution in the mouth for some minutes and swallow the liquid) To collect daily data we used the "evaluation OM" datasheet, now in use in our Unit. At the end of the treatment or when changing the oral solution, patients were given the product satisfaction questionnaire. Results: We collected data from 20 patients: 16/20 (6 MM, 1 lymphoblastic lymphoma, 4 HD, 4 LNH and 1WD) using Orasol concluded the treatment with Orasol (80%). When admitted 8 patients had a G0-G1 mucositis. At discharge, 16 patients had a G0 mucositis as shown in table 1. Four patients interrupted the treatment with Orasol because they did not like the taste and were put on Benzidamine oral solution and Bicarbonate+lidocaine. Conclusions: Orasol has shown effi cacy in mucositis prophylaxis in patients aff ected by lymphoma and multiple myeloma undergoing autologous HSCT with a melphalan containing regimen. Compared to Benzidamine solution, Orasol is more versatile because does not contain alcool and can be swallowed.
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Completion of referral forms and compliance with the use of pre-defi ned priming protocols improves outcome of stem cell collection J. Powell, J. Ingram, M.O. Wilson, J. Thompson, S. Phillips University Hospital of Wales (Cardiff , GB) The Stem Cell Collection (SCC) facility at the University Hospital of Wales is a core component of the Blood and Marrow Transplant (BMT) Programme which serves the population of South and West Wales. Historically, up to 50% of patients were noted to fail mobilisation, with a high rate of prescribing errors for G-CSF and several adverse events resulting from a lack of essential information such as infectious disease markers prior to SCC. Poor compliance with the use of pre-defi ned priming protocols also led to ineffi ciencies in the service. As a result, a formal referral system for all patients requiring SCC was introduced and managed by the senior nursing staff within the SCC facility. All patients require a referral form to be submitted to the SCC facility prior to a date of collection being agreed. This form provides information on venous access, medications which may aff ect the procedure and essential infectious disease markers. Following allocation of the date of SCC, the referrer must then select and complete the appropriate pre-defi ned priming protocol which is aimed at minimising prescribing errors and details the predicted day of mobilisation. The outcome of 126 referrals for SCC received between May 2011 and November 2012 were analysed. The diagnoses were Myeloma n=57, Non-Hodgkin Lymphoma (NHL) n=49 and Hodgkin Lymphoma (HL) n=20. Compliance with the use of priming protocols was high with no protocol submitted in just 5 cases. The priming protocols were able to accurately predict the day of SCC in 86% of patients receiving G-CSF with 100% of patients mobilising within 2 days of prediction. Patients receiving cyclophosphamide/GCSF, 33% primed on the predicted day of mobilisation with 83% within 1 day of prediction. Other chemotherapy regimens resulted in 69% of patients being collected on the predicted day with 91% within 2 days of prediction. All patients who mobilised following a planned GCSF/Plerixafor priming regime collected on the predicted day. The number of adverse events occurring as a result of prescribing errors was low with just 1 protocol violation. In conclusion, the data supports the current mechanism of referral for SCC. The use of such priming protocols provides an accurate prediction of the day of mobilisation thereby maximising the effi ciency of the service. Additionally, compliance with the referral system minimises adverse events thereby improving outcomes of SCC.
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Prelixafor: trick or magic ? S. Vieira, D. Monroe, A. Anosike The London Clinic (London, GB) Introduction: Plerixafor (MOZOBIL ®) is an antagonist of α-chemokine receptor CXCR and one of the recent additions to the Haematology discipline; it is used as a stem cell mobiliser. CXCR4 α-chemokine receptors are important in hematopoietic stem cells homing to the bone marrow and in hematopoietic stem cell quiescence. It is indicated in combination with Granulocyte Colony Stimulating Factor (GCSF) for Peripheral Blood Stem Cell (PBSC) collections in the Multiple Myeloma (MM) and Lymphoma patient groups with a poor mobilisation history. Method: Our data was collected prospectively. 35 patients (two patients were included twice as they received Prelixafor on two separate occasions) received Plerixafor for PBSC collection between May 2009 and September 2012. Patients met the criteria prior to treatment, except three patients with low platelet counts. Five patients had an underlying documented medical problem (cortochondritis, asthma, hypertension and glaucoma).
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Result: 25 of the patients were diagnosed with MM and six with Non-Hodgkin's Lymphoma (NHL), two patients had Hodgkin's Disease, one had Neuroblastoma and one Walderstorm's Macroglobulinameia. All patients received four consecutive days of GCSF 10 μg/kg prior to Plerixafor. Plerixafor (0.24 mg/kg/day) was given 10 hours before the PBSC collection and GCSF was repeated one hour prior to PBSC collection on the morning. There were no side eff ects observed in these episodes. 26 patients required single dose, 10 patients required a second dose , and only one patient received three dose of Plerixafor. For all cases, the target CD34+ count was 4 x 10 6 cells/kg of recipient body weight. Two patients responded extremely well with a CD34+ count of 21.79 x 10 6 cells/kg and 15.16 x106 cells/kg achieved. 13 patients achieved the target of 4 X10 6 cells/kg or above. However 22 patients failed to achieve to reach target. 16 of these patients had adequate amounts of CD34 count for an autologus transplant. Four patient failed to mobilise with CD 34+ <2 X10 9 cells/kg. Only six patient had > CD 34+ <2 X10 9 cells/kg one of this patient had no CD34+ at all.
Conclusion: Plerixafor was used at The London Clinic recently with mostly favourable outcomes. According to our study, Plerixafor has defi nitely made a positive diff erence in 40% of our patients and 83% had enough cells for an autologus transplant. However, results are inconclusive due to small patient numbers. Ongoing studies with new patient experiences are needed. S483 associated with a clinically signifi cant incidence of febrile neutropenia. The major cause of treatment morbidity and mortality for patients with acute leukemias is due to infection with prolonged neutropenia. Neulasta (pegfi lgrastim) is known to be as effi cacious as Filgrastim in reducing chemotherapy-induced neutropenia and licensed for autologus stem cell transplantation. In our centre Neulasta is also used post chemotherapy in order to shorted neutropenia and therefore reduce febrile episodes, hence hospitalisation. Our aim was to explore whether neulasta could be usefull in other chemotherapy treatments. Methodology: Our study was carried out retrospectively. It is included 79 patients with haematological malignancies,they were selected randomly. All patients included in this study were treated as in patients. Patients' data are presented in Table I . Even though R-CHOP is given as out patient treatment; there are 4 patients who received R-CHOP included in this study due to their tendency to become neutropenic after each cycle. Therefore it was considered these two patients should be included. Results: The majority of patient included in this study suff er from acute leukaemia and Non Hodgkin Lymphoma (See Table I ). Chemotherapy regimens are given also given in table I. Most of our patients had a quick Neutrophil recovery (mean value: 6.5 days). There are huge amounts of studies published regarding the duration of neutropenia induced by chemotherapy, which states that it is approximately 2-3 weeks, 54.4% (43) of patients had a neutrophil recovery 10 days or less, 46.9% (37) of our patients didn't have febrile episode at all and 22.8% of patients were managed as out patient. Only 8.8% of patients required additional GCSF. Conclusion: In our unit we believe neulasta was achieved favourable outcomes for our patient population by shorten the neutropenic period and reducing the febrile episodes, therefore hospitalisation. Problem: There is evidence of only a few studies related to serious errors committed by nursing students during clinical training. Furthermore, in literature were not retrieved studies on professionals working directly with students. This knowledge is important to ensure safety in treated patients. Aim: The aim of the study was to describe types, causes and consequences of serious errors made by nursing students during clinical training, prevented by preceptors, in order to implement preventive strategies. Material and methods: A qualitative phenomenological study was performed on Padua Hospitals' Nurse Mentors and Trainers operating for Padua University Bachelor in Science of Nursing and in a Bachelor in Pediatric Science of Nursing. Hematopoietic stem cell transplant Units were been selected as well. A semi-structured interview was conducted to professionals who agreed to participate following an invitation by e-mail sent to all 179 Mentor. The study was approved by the Hospitals management and conducted assuring participants' privacy. Quantitative variables were expressed using simple descriptive statistics, while the Colaizzi method was used to analyze the responses to the interviews. Results: They were selected 15 useful interviews. Seven main themes were identifi ed: type of error, error interception, error recovery, place, causes, consequences and measures to the student/the referent. Most errors occurred at the bedside and the participants recognize two causes: students' behavior or the lack of knowledge. The practice was managed mainly with a discussion between the student and the referent; there was also a communication with the university faculty and the student had the opportunity to repeat the period of clinical practice. Discussion and practical implications: The study off ers signifi cative evidence useful for the monitoring, prevention and manage of potential serious errors made by students involved in clinical training. These knowledge are useful to increase patient safety by implementing preventive measures such as: places where the errors occur, modality and reasons of mistake, event's management and students tutorship following the mistake. Finally, even if the research was conducted in a specifi c formative place, results may be useful for practical application and further studies, such us: guideline production for the management and the evaluation of these students, and discussion between students and professionals about the risk factors.
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Perfect storm: care complexity in a patient undergoing bone marrow transplantation for sickle cell anaemia M. Dubali, F. Ponzo, T. Innocenzi, V. Comanici, L. D'Aversa, D. Francesconi International Centre of Bone Marrow Transplantation (Rome, IT) Objectives: Sickle cell anaemia (SCA) is a genetic disorder predominantly aff ecting Africans. SCA has many complications, and Bone Marrow Transplantation (BMT) is the only cure. In patients with SCA sibling HLA donor, BMT improve life quality having a large psycho-social impact for the families. The success rate of BMT in our SCA patient is 96% survival and disease free survival. Methods: We describe here a 15 year SCA female from Nigeria, diagnosed at age of 1.5 years. As a child had fever, painful joint crisis and breathing diffi culty. She never had ischemic events. Patient considered BMT due to pains and respiratory distress. The clinical protocol was: BU 12 mg/kg/day, CY 200mg/kg. GVHD prophylaxis: CyA 5 mg/kg/day, Metil-PND 0.5mg/kg; MTX 10 mg/m 2 (post). Donor was matched HLA related sibling. Engraftment was 100% donor's 20 days after BMT. Nurses provided patient with direct care, monitoring and hospitalization. Results: Thirteen days after BMT she started to present complications, such as fever, seizures, GVHD skin, gut GVHD, rectorrhagia, diarrhoea, drug toxicity, oropharyngeal infections, intermittent abdominal pain, ascites, pressure ulcers, and pancreas infl ammation. I would like to say that the treatment with a radical cure of a hemoglobinopathy such as SCA presented a set of complications to the patient with leukemia. In addition, those patients having had embolic events as infants represent most clinical complications at the same time during the BMT. Despite all the arrangements, the patient died 35 hours after ascites drainage. Conclusion: In our case, the patient had several BMT-complications that only experienced professionals can handle. Also based on our experience, we are convinced that the SCA patient undergoing BMT can promote very fast several fatal compliances. Objectives: Sickle cell anaemia (SCA) is an autosomal recessive genetic disorder predominantly aff ecting Africans. In Nigeria, the prevalence is 20 per 1000 births and about 150 000 children SCA patients born annually with carrier rate 24%. The SCA has many complications, and bone marrow transplantation (BMT) is the only cure. In patients with SCA and sibling HLA donor, BMT improve a better quality of life, and has a large psycho-social impact. In our centre we have performed 37 BMT for SCA with success rate: 96% survival and disease free survival. Methods: The 12 year old patient was diagnosed with SCA at 1 year of age. Treatment protocol with: Bu 3.7-Cy 200-Fludara 30. GVHD prophylaxis was: CyA I.V; six short MTX 10mg /m 2 and CTX 7.5 mg/kg. The donor was the HLA identical patient's sister. Chimerism reached 100 % donor. In post BMT period, clinical complications were: intestinal GVHD III; fever (streptococcus gram +), skin GVHD IV; diarrhoea (>10 times/day), and fi nally, CMV re-activation.
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Results: The cetaceous GVHD was presented erythematous bullous, spreading all over the surface of the back, even with blood loss. During the aplastic phase great attention was given to the patient's systemic and local infections. Nursing management included: skin dressings, intensive blood/platelets transfusions, photo-aphaeresis, intensive pain control and infection control applying platelet gel to bleeding surfaces with use of sterile drip. During skin GVHD accompanied with aplasia, protecting skin was carefully done. Back dressings were done in total aseptic conditions changing them twice a day. After intensive treatment, both pharmacological and cutaneous, application of medication with paraffi n gauze and platelet gel was done. During BMT hospital admission days dressings were carried twice a week applying the regenerative products. Currently, total skin epithelisation is achieved and the GVHD is resolved. Conclusion: It is very diffi cult to ensure the care of such a patient in the absence of an excellence clinical "structure". By uniting specialized professionals and using new drugs and technology the best quality treatment was achieved.
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Distress thermometer: monitoring, assessment and early intervention in HSCT patients experiencing emotional discomfort L. Rinaldi, A. Errico, L. Galgano A.O.U.Careggi (Florence, IT) Background: Patients undergoing a HSCT (autologous or allogeneic) in our unit are dealing with aggressive conditioning regimens, a protective isolation period and adverse events. We have to add further problematic factors such as family, work, social relationships, money, etc. A person with all these burden may develop an high anxiety and stress level for a long time, making the hospitalization period very complex. In order to manage these problems, we have introduced the use of the "distress thermometer" that allows us to assess the patients discomfort and give us the chance to gradually manage their problems. We started to use the "distress thermometer" in November 2011. Objectives: 1) maintaining the "distress thermometer" within the "controlled discomfort" (range 0-3). 2) identifying a threshold to activate a psycho-oncologist support. 3) identifying other problems associated to distress. Methods: We planned the administration of the "distress thermometer" to all patients undergoing HSCT: 1) before the hospitalization; 2) every 7 days after the tranplant. When the "distress thermometer" is > 4, attending physician is informed.
Data are collected through specifi c forms and entered into a database at discharge from BMT ward. Autologous and allogeneic transplantations were analyzed separately.
Patients showing communication problems (language, restricted ethnicity, cognitive impairment, minors) were excluded. Conclusion: "Distress thermometer" was shown a fast and reliable tool to assess the distress pattern of patients undergoing HSCT. "Distress thermometer" can be easily implemented in the nursing armamentarium to improve the global care of transplant patients.
P1350 White blood cell depletion in early pregnancy: the Imperial College Healthcare Trust experience R. Haynes, E. Dannie, J. Apperley Imperial College Healthcare NHS Trust Hospitals (London, GB)
Introduction: Diagnosis of cancer is devastating for patients, and is even more so when the patient is a 23 year old 9-week pregnant primagravida diagnosed with chronic myeloid leukaemia (CML). On presentation the white blood cells (WBC) was 324, occasional headaches and tiredness. The treatment of chronic myeloid leukaemia (CML) during pregnancy is challenging and is a matter of continued debate. The main consideration here is to manage the WBCs eff ectively without the use of chemotherapeutic agents. A joint clinical decision was therefore made that it was safe to carry the pregnancy to the end of the second trimester by white blood cell depletions (WBCD ) alone therefore safeguarding foetal exposure to potentially harmful agents. Methods: In February 2012 the Apheresis Team (AT) had the privilege and the challenge in managing white blood cell depletions (WBCD) on this patient. The data on WBCD in primagravida CML is sparse. AT was at the forefront in meeting the needs and the expectations of the patient and the families. AT went overboard and became innovative making sure that the intervention (WBCD) we were about to do encompasses the "Traditional Old Paradigm" approach: fi rst do no harm. These were the AT preparations prior to WBCDs. With appropriate consent was sought the support of the scientifi c head of the Terumo BCT for both the AT during the procedures, and to collate data on the effi ciency of the two apheresis machines: Spectra Optia compare to Cobe Spectra on WBCDs. 12 WBCDs were performed by the highly trained and well experienced apheresis nurses. The Bone Marrow Coordinator was accessible for monitoring patient`s status clinically . AT did pre and post procedure conference with the haematology consultant responsible for the patient. Our results showed that after 12 depletions the WBC count had stabilised.
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We collated valuable scientifi c information comparing the efficiency of Cobe Spectra and Spectra Optia apheresis machines on WBCDs. The fi ndings will be presented by the Imperial College NHS Healthcare Stem Cell Lab at the EBMT Data Management. AT has gleaned valuable apheresis knowledge and experience in WBCD in pregnancy. In conclusion CML in early pregnancy can be managed safely by leucodepletions alone. The patient is now a proud mother of a healthy 6 month old baby girl.
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Patient feedback after paediatric stem cell transplant as a lead for improving care H. Rip-Mekelenkamp, H.C.A. Verweij-Baars, F. van Iperen, A. van der Tang, W.J.W. Kollen Leiden University Medical Center (Leiden, NL) Introduction: Stem cell transplantation (SCT) programs in the Netherlands require JACIE accreditation by law. Patient satisfaction is an important part of a functioning quality management system and an indicator for improvement of care. Objective: Collection of feedback from pediatric SCT patients (and/or parents) that can be used to improve care in the SCT unit of the Leiden University Medical Center. Method: Since June 2011 an on line questionnaire (OQ) was sent to parents of children just before discharge from the hospital after SCT. The questionnaire existed of 16 questions on a fi velevel Likert-scale, ranging from 'dissatisfi ed, moderately satisfi ed, relatively satisfi ed, clearly satisfi ed, to very satisfi ed' , and one open question. During the same period nurses used a questionnaire in their discharge conversation (DC) based on the same topics as the OQ. Topics included hospital admission, treatment and attitude of nurses/physicians, information, autonomy/respect and discharge/follow-up. Results: In about one year 31 OQ's were sent. The response rate was 61% (19). In the same period 15 oral questionnaires were carried out. Results of the OQ's are shown in table 1. For all topics the most chosen value was 'clearly satisfi ed' . Remarkably, communication between persons was valued as 'moderately satisfi ed' (31%). This was confi rmed by answers to the open question of the OQ. The DC's gave additional information. Patients were positive about special attention during hospital admission, but also mentioned some aspects that need attention. Treatment and care/cure of nurses and physicians was valued as 'good, correct, and child-oriented' . The provided Information was 'fi ne and clear' . More specifi c the patient information guide of the department was indicated as convenient. Discharge and follow up was valued as 'well prepared' . In some cases sudden decisions for discharge were made resulting in a lot of information for the patients in a short interval.
Conclusion: The response rate to the OQ was good. Although it was too time consuming to use the oral questionnaire during all the DC's, it did give additional information. Based on the feedback of patient's and caregivers, a plan was formulated for further improvement of care. The described method provides the possibility to continuously measure patient and parent satisfaction and off ers an unique tool for quality improvement. Objective: Prevention of infectious diseases in Hematopoietic stem cell transplanted patient (HSCT) in the underdeveloped country like Nigeria is very important due to high prevalence of infectious disease and lack of diagnostic/therapeutic facilities especially for fungal/fungal diseases. The Nurses in the University of Benin Teaching Hospital Stem cell Transplant Centre adopted a standard protocol to prevent the spread of infectious disease in HSCT patients. Method: All HSCT patients were nursed in isolation rooms with hyperfi lteration machines, rooms were fumigated with 7% tar acid phenol plus cryselic cresole, petri-dishes are placed in rooms, water from taps and swaps from surfaces are sent every 3 months to the labs for cultutre,the use of liquid detergents, bleach solutions(sodium hypochlorite 3.8%) and antiseptic disinfectant (dichorometaxylenol 2.5%) for cleaning the fl oor three times daily, Bleach solution is poured into the closet of the toilet in all the isolation rooms daily, good personal hygiene with hand wash using chlorhexidine gluconate then absolute alcohol,wearing of caps, face mask and gowns before entering the isolation rooms. Utensils are soaked with Milton tablet (sodium dichlorocyanurate 19.5% in 1.5 litres), all materials are cleaned with 70% alcohol daily, Patients have daily bath, skin protected with oily cream, oral care, oil conjunctiva with lacrimal gel and daily dressing of central venous catheter. Results: The use of these preventive protocols have reduced the incidence of infectious disease in our transplant centre except only a single recorded event of infection of the central venous catheter site with Pseudomonas infection in the fi rst transplant patient. This infection was traced to the batch of antiseptic used to clean the venous catheter site.To prevent further reoccurrence a sample of all antiseptic batch is sent for culture before use. Conclusion: Prevention of infectious diseases in a developing HSCT will require that staff abide to standard approved protocols. Although we had reduced incidence of infectious diseases in our centre but with only two recorded transplant we need to put these protocol into test and improve on them subsequently.
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[P1351] P1353 NHS ventures, a working partnership bewteen private and public sectors. striving for excellence in private bone marrow and stem cell transplantation T. Barias, E. Dowling, H. Iley, C. Jackson, L. Mills, D. Simpson NHS Ventures (London, GB) Harley Street @ UCH is the United Kingdom's fi rst shared venture between a private healthcare facility and a NHS trust. Founded by HCA International (HCA) in 2006, NHS Ventures provides high quality treatment for Haematology, Bone marrow and Hematopoietic stem cell transplant patients (HPSCT), within state-of-the-art facilities, supported by the latest technology and the infrastructure of large NHS hospitals. The aim of this abstract is to evidence through patient satisfaction surveys, service level agreements, staff and consultant interviews, that there are many benefi ts to the quality of care provided to HPSCT patients in a shared venture setting. Through service level agreements (SLA's) HCA are able to access the fi rst class facilities off ered by UCLH such as the emergency outreach and critical care services, imaging and radiology departments, and despite care being consultant lead, we are able to utilise the services of the house offi cers and registrars within the trust on a 24 hour basis. All transplant patients are also supported by the clinical expertise of the bone marrow and HPSCT team, including a clinical nurse specialist who supports them in their pre and post transplant care. The SLA's are there to benefi t both parties and as a result of the shared venture, HCA provide funding to the trust which has been utilised in providing increased numbers of specialist nurses and medical teams within the cancer care division. HCA also pay a rental fee to UCLH and work in a cost share partnership. With increased revenue comes better availability of resources, staff and services, which has a positive impact on the quality of patient care available at UCLH. On questioning, our consultants stated that the benefi ts of shared care were in their opinion; the presence of all specialities on site, the specialist intensive care unit with in the hospital, around the clock medical cover, high quality staff recruitment in a world renowned and respected facility. NHS ventures collected Patient satisfaction questionnaires from September 2011 to September 2012 (see graph). Key fi ndings show that across the board patients' satisfaction with nursing care averages at 96.3% and their overall perception of quality of care also averages at 96.3%. Crucially the surveys also found that 100%of patients would recommend NHS Ventures. Through auditing the satisfaction surveys NHS ventures are learning from their patients and striving for excellence across the board.
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Management of citrate toxicity in neurology patients undergoing therapeutic plasma exchange: the Imperial College NHS Trust experience R. Haynes, S. Thomas, D. Paul, F. McManamon, J. Gururaj, E. Dannie Imperial College Healthcare NHS Trust (London, GB) New studies show that therapeutic plasma exchange (TPE) can help treat certain infl ammatory diseases of the central nervous system. These diseases involve demyelination. This is when the protective coating around certain nerves is damaged. The diseases also involve infl ammation. TPE has been shown to be most effi cacious for severe exacerbations and acute crises in this group of patients. In experienced hands, TPE is extremely safe although hypotension, dizziness, and perioral tingling may occur either during or following apheresis. Most of these reactions are rapidly recognised and reversed, and are rarely serious when acted on accordingly. Methods: Neurology patients referred for TPE have co-morbidities such as ascending paralysis, sensory and autonomic disturbances which aff ect changes in blood pressure and cardiac rhythm such as arrhythmias. Sometimes TPE could exacerbate or compromise patient clinically. It is of paramount importance, therefore, that the following patient considerations are in place prior to eff ecting plasma exchange. The most common adverse reaction is citrate related due to acid citrate dextrose-A (ACD-A) we use with the procedure. Citrate binds free ionized calcium to prevent blood from clotting in the extracorporeal line during apheresis procedure. Prior to TPE, it is the responsibility of apheresis nurse to do a thorough check on the diagnosis, medical and pharmacological history, haemodynamic stability, vital signs, electrolytes imbalances,clotting profi le and history of allergies. Haematology input is accessible for advice as TPE belongs to the realm of haematology. In our apheresis centre we give slow infusion of calcium gluconate during the procedure. This has remarkably reduced the incidence of citrate toxicity in neurology patients. Patient education is of crucial importance. Signs and symptoms of citrate toxicity are reinforced so that early detection and proactive intervention could be achieved if this problem so ensues.
In conclusion, by considering all of these factors and adapting a pro-active TPE interventions in preventing citrate toxicity, better apheresis care of neurology patient is achieved thus enhancing patient experience and shortening the length of stay in hospital.
[P1353] P1355 Plerixifor: killing two birds with one stone, the Imperial College Healthcare NHS Trust experience R. Haynes, O. Brokka, S. Thomas, D. Paul, F. McManamon, M. Lasa, R. Palani-Kawandar Imperial College Healthcare NHS Trust (London, GB) Introduction: Autologous stem cell transplantation is now an integral part of treatment for patients with multiple myeloma (MM), relapsed non-Hodgkin`s lymphoma (NHL), germ cell tumour (GCT) and patient who failed etoposide chemotherapy priming and granulocyte colony stimulating factor (Gcsf ). Obtaining suffi cient stem cells remains a challenge in using this treatment strategy as a number of patients will fail mobilisation with conventional methods. The introduction of the CXCRA4 antagonist Plerixafor provides an alternative mobilisation option especially in patient who has failed etoposide +Gcsf mobilisation due to several lines of treatment in the past. At EBMT 2010 Imperial College haematology apheresis suite presented a data, collected retrospectively, on the effi cacy of Plerixafor as an alternative mobilisation option for patient who failed on the conventional chemotherapy priming. The drug was well tolerated. No adverse eff ects were reported. Method: At Imperial, Plerixafor was administered at an identical dose regimen to the licensed dose with patient receiving the drug 10-11 hours before each apheresis session. This drug regimen is inconvenient to the patient, imposing overnight in-patient infrastructure which may not be readily available. This is a big issue in our already overstretch bed capacity. The active role of nurses in eff ecting patient-friendly innovative practises to enhance patient treatment experience is well documented. The apheresis team ever conscious of the fi nancial constraints of the times conferred with the bone marrow coordinators to review our nursing practice in giving plerixafor based on several studies showing prolonged mobilisation of stem cells in patients given plerixifor + Gcsf. With these two main reasons in mind, the consensus was to create a patient-friendly protocol on late afternoon dosing of Plerixafor. The apheresis nursing input in early dosing of plerixafor was of crucial importance. It incorporated a comprehensive educational element for the patients, the apheresis team, the bone marrow coordinators and pharmacy staff . In conclusion late afternoon dosing of Plerixafor is a practical and cost eff ective solution to our problem which benefi t patients and Imperial College Healthcare NHS Trust.
P1356 The use of PICC in haematopoietic stem cell collection A. Trunfi o on behalf GITMO
The most used central venous catheter (CVC) in our department has always been the tunneled type Groshong. It was rarely used the access in the jugular or in the femoral vein. Towards the end of 2009 we began to evaluate the opportunity and the possibility to use a diff erent device less invasive, free from implant related complications and more suitable for patients for whom the CVC tunneled was inadequate. The best choice seemed to be the PICC (Peripherally Inserted Central Catheter). Between November 2010 and December 2011 we implanted 110 PICC including 59 patients with a planned collection of peripheral blood stem cells . The initial enthusiasm for the new activity, supported by the positive feedback from patients, had then to deal with problems that arose with the fi rst 7 patients at the time of the collection of stem cells. The transfusion doctors reported the inability to perform the procedure as the machines were constantly in alarm and they were forced to use peripheral venous access with considerable discomfort for patients. The resolution of this issue was of paramount importance. With the help of a Clinical Specialist in vascular access an in vitro test was performed with a 4 french valved silicone catherer that at the length of 30 cm allowed the proper functioning of cell separators; therefore it was decided to try to implant shorter PICC to have less resistance during the harvest of HSC (hematopoietic stem cells). For the following implants some important parameters were taken into considerations (in addition to the tip of the PICC placed in the atrium caval junction):
• To perform an installation as high as possible using the lower part of the upper third of the arm • To implant always from the right • To use an open tip PICC and the greater caliber tolerable by the patient's veins. The 20th PICC, positioned according to these criteria, was the fi rst of a series of devices that have met the needs of apheresis that were 47 in 39 patients on 10/01/2012. The data analysis shows there is not a substantial diff erence in the quality of collections made with diff erent types of catheter and even the length (within certain limits) aff ects relatively the fl ows, the duration and the volume processed. Background: Chemotherapy-induced nausea and vomiting (CINV) is undoubtedly one of the most common forms of complications and with greater impact on quality of life (QoL) of patients undergoing hematopoietic stem cell transplantation (HSCT). Objectives: to defi ne treatment emetogenicity (TE) in the commonly used conditioning regimens (CR) for hematopoietic stem cell transplantation (HSCT); to suggest appropriate chemotherapy and/or radiation-induced nausea-vomiting (C/RINV) prophylaxis. Methods: An assessment form had been fi lled out by each of the 6 center of the RTN. The form included the following items: incidence, monitoring (scales, recording instruments), prevention and treatment of CINV; in order to better analyze the prophylaxis of CINV, it has been asked to detail the pattern of prophylaxis of a commonly used conditioning regimen for autologous transplant (high-dose melphalan in a single administration, MEL200). According to guidelines (MASCC/ISOO, ESCO, ASCO), daily TE was estimated as high (HE), moderate (ME), low (LE) and minimal (minE); appropiate prophylaxis was suggested; in this study, in case of multiple doses of the same drug in a single day, treatment emetogenicity was calculated considering the total amount administered within 24 hours; in case of single day multiple drugs or chemo-radiotherapy combination, treatment emetogenicity was calculated considering greatest emetogenicity treatment only. Daily prophylaxis has been suggested based on guideline recommendations. Results: Twenty seven CR were examined, for a total of 147 treatment days, 115 (78.2%) with single-agent (chemotherapy in 94 (63.9%) or radiotherapy in 21 (14.3%)) and 32 (21.8%) with multiple-agents administration. TE was: HE, ME, LE and minE in 67 (45.6%), 34 (23.1%), 6 (4.1%) and 40 (27.2%) days, respectively. Maximal conditioning TE was: HE, ME, LE and minE in 21 (77.8%), 5 (18.5%) 0 (0%) and 1 (3.7%) CR, respectively. Subsequently, prophylaxis need and type were established for a total of 218 days (conditioning period and the following 3 days) with the following results: prophylaxis and no-prophylaxis recommended in 178 (82%) and 40 days (18%), respectively (details Table 1 ). Conclusions: C/RINV risk was high or moderate in almost all regimens, so that prophylaxis need is high. The suggestions of prophylaxis, although derived from existing guidelines, have a low level of evidence, especially for new drugs (aprepitant and palonosetron).
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Conversion of medical haematology oncology ward to a specialised BMT ward K. Baker, G. Fairnham, A. Hill, A. Rudnitskiy Liverpool Hospital, NSW Health (Liverpool, AU) Liverpool Hospital originally had a medical ward turn into a haematology oncology ward which progressed to PBSCT (Peripheral Blood Stem Cell Transplant) and recently Allogeneic Bone Marrow Transplants (BMT). Allogeneic Bone Marrow Transplantation is a complex procedure which requires extensive monitoring of the treatment and its possible side eff ects. to infuse in about 15 minutes bedside. It has been created a scale for measuring the side eff ects during the infusion. it is requested the presence in the room next to the patient during the infusion of all the bags; if the bag stem cell doesn't fall with a speed that it can allow the administration terms established within 15 minutes, the nurse is authorized to infuse with a relatively constant speed with a syringe connected to the system in an aseptic manner. Results: no patient showed side eff ects during or after the infusion. The times of administration are shorter or overlapable to infusions carried out with the previous method.
Conclusions: the standardized procedure jacie is fully nursemanaged. The nurses group is discussing if this activity has increased or not the workload. Defi nitely increased the expertise, autonomy and competence of the nurses. Stronger team work. Patients with sickle cell may require exchange red cell transfusions for acute complications, stroke prevention, iron overload issues, prior to complex surgery and prior to blood and marrow transplantation (BMT). The development of the Spectra Optia ® has made automated exchanges using peripheral access in the sickle cell population feasible, cost eff ective but more importantly for paediatric patients, less invasive. In 30 months (May 2010 to November 2012) we performed 105 procedures successfully (102 of those were carried out on peripheral venous access) out of 110 procedures attempted in a total of 33 patients. The mean age of patients on their fi rst exchange was 11 years and 1 month, ranging from 4-18 years of age. 22 of the 33 patients received a single procedure; the remaining 11 patients received multiple procedures either due to being on a regular exchange program, multiple acute crisis episodes, or several surgical procedures. 14 patients were exchanged due to an episode of acute crisis, 10 patients were exchanged pre BMT and surgery, 4 patients were pre surgery only, and 5 patients were on a regular exchange program. Out of the 5 failed procedures, 1 patient failed to receive a successful automated exchange on the Spectra Optia ®, this incident was reported to the company and documented to be a possible technical error. 2 patients' procedures failed due to venous access; however these patients proceeded to have 3 successful procedures via peripherally inserted central lines (two femoral and one subclavian). 2 patients proceeded to have successful automated exchanges peripherally at a later date, despite being originally abandoned early due to loss of venous access. The inlet access to the machine ranged from 17G-22G peripheral access in upper and/or lower limbs, except for the aforementioned 2 patients who required a central line. The return access ranged from 20-22G, however, over time no benefi t was seen from using anything other than 22G for return access, and is therefore current standard practice in our Trust in paediatrics. In summary, automated exchange transfusion in the paediatric population is safe and feasible with peripheral access using the Spectra Optia ® apheresis system. The Haematology unit at the Hammersmith Hospital has undergone a major nursing restructure over the last two years to address high vacancy rates and poor staff retention. The strategy proved successful in reducing vacancy rates that peaked at 40% to currently <10%. Nursing establishments and job descriptions were revised to increase the number of nurses in posts at a more senior band from the existing nursing cohort to keep pace with a competitive London healthcare market. However, the benefi ts of that work, which placed a signifi cant fi nancial cost pressure on clinical services is now only beginning to be demonstrated, as nursing teams are developed, utilising the specialist haemato-oncology knowledge base that the senior nurses provide. Performance indicators such as patient experience and quality improvement framework (QIF) targets demonstrate a direct correlation with improved staffi ng levels and quality of care. The current challenge is maintaining what are deemed to be safe staffi ng levels, whilst also managing the pressures of cost saving initiatives caused by fi nancial defi cits in organisations. SCT units typically have higher ratios of skilled to unskilled nurses, and higher nurse to patient ratios. Furthermore, the variable levels of patient acuity are not always clearly demonstrated to senior health care managers and commissioners to safeguard standards of care at a time when the productivity of clinical services are being subject to closer scrutiny and workforce reviews. Currently, there are no national guidelines for minimum staffi ng levels for SCT/haematology units. However, there are general agreed principles outlined in the quality measures of regulatory bodies (e.g. Joint Accreditation Committee-ISCT (Europe) -JACIE, European Group for Blood and Marrow Transplantation -EBMT, British Committee for Standards in Haematology -BCSH, and Cancer Peer review standards) that apply to staffi ng levels in specialist haemato-oncology centres providing a minimum of level 2 care. These state that staffi ng levels should refl ect, and be able to respond to, the complexity of treatment regimens, variable acuity levels and have capacity to provide 1 to 1 nursing when required. The data from a recent benchmarking exercise undertaken by the Shelford Group in 2012, showed variations in staffi ng levels across comparable haemato-oncology centres that requires further analysis and supports the need for further joint working to benchmark and share best practice.
P1361
P1363
P1365 Independent double checking (IDC) R. Johnston, S. Pike, C. Duran Great Ormond Street Hospital (London, GB)
Background: The Nursing and Midwifery Council (NMC, 2008) advice that all intravenous (iv) medications needs to be double checked. The practice on the Bone marrow transplant (BMT) wards at Great Ormond Street Hospital (GOSH) had historically been for nurses to single check also iv medications. The requirement to meet standards of double checking iv medication drove the need to review ways to improve drug administration to become safer and more eff ective at GOSH. This led to the implementation of Independent double checking (IDC). The process of IDC involves categorising iv medication into 'high risk' and 'low risk' drugs. For the 'low risk' group only the actual calculation of the prescribed dose to the corresponding volume of medication needs to be double checked. All other aspects of drug administration would lies with the 'giver' . For 'high risk' drugs on the other hand all aspects of administration needs to be double checked and both 'giver' and 'checker' are equally accountable. This includes for both checker and giver to check the dose and volume, as well as any specifi c requirements, patient identity on administration and rates etc. All checks needs to be independent, i.e. the checker and giver are each doing their own complete check rather doing a check together. These checks need to be carried out silently as far as possible in order to reduce confi rmation bias. Aim: We would like to present how the processes of IDC have been implemented and sustained as standard practice on GOSH to improve the safety and care for our patients.
Conclusion:
Benefi ts of IDC:
• Increasing nursing effi ciency in drug administration • Clear roles and responsibilities of drug checker and giver • Improved quality of checks
• Increased nursing presence at the bedside. Challenges identifi ed:
• To ensure name-band compliance with prescription checks • To ensure 'silent checks" to avoid confi rmation bias.
• A variety of activities were available, ranging from golf to darts, athletics to bobsleigh. We received very positive feedback from our participants and their families. The opportunity to participate in the games allowed patients and their families to network with other recipients of solid organ transplants together with haematology patients. When asked what they had gained from their experience they expressed that they had enjoyed meeting other people in the same situation as themselves, that they had great fun and also a satisfying feeling of self accomplishment. Those that had participated very much looked forward to attending the following years event which was to be held in Belfast. We are hoping that more patients will come with us to the games in future years so that they may experience all that their predecessors had in 2011.
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Is it possible to increase the amount of physical activity for isolated haematological patients by educating the nursing staff in motivational interviewing?
S. Vejby Uppsala University (Uppsala, SE)
Purpose: To investigate if the physical activity level of isolated haematological patients can be improved by using individual care plans and a motivational interviewing approach (MI), as well as if an increasing level of physical activity aff ects the need of transfusions, analgesics, antibiotics and number of days in isolation. Methods: An experimental design was chosen and the intervention group was compared to haematological patients at a ward in the southern Sweden. The staff at the intervention ward received a short MI education. Sixteen patients were included in each group, 13 patients completed the study at the intervention ward and 12 in the comparing group. The patients wrote daily activity diaries and every movement was counted as METs (Metabolic Equivalent of Task), a validated way of measuring physical activity. Results: A signifi cant diff erence in METs means was seen between the two groups, 11,1 METs per day in the intervention group compared to 6,8 METs in the comparing group. A diff erence in the need of transfusions, analgesics, antibiotics and the number of isolation days was only seen in time of isolation. There were signifi cant diff erences in all tested variables except for the number of blood transfusions when all patients together were categorized into three groups according to activity level. Presentation from admission to the BMT Unit to the discharge day.
Results: The issues we have discussed and would like to share with colleagues in our profession are:
• Experience and diffi culties of the nursing staff in the care of the patient with CEP.
• Nursing activities related to the individualization of care. Conclusions: After a complex therapeutic process of BMT, we enabled the patient to lead a normal life, just like any other child of the same age.
P1371 A multidisciplinary approach to provide culturally competent care to Arabic families of Islamic traditions on a paediatric bone marrow transplant unit S. Tang, K. Elison, D. Landery, M. Moses Children's Hospital Los Angeles (Los Angeles, US)
Arabic speaking families receiving westernized medical care for their child in a foreign country can be a stressful and frightening time for families. The unfamiliar surroundings, the inability to communicate and the diff erences in cultural practices can lead to miscommunication and misunderstandings with the health care team. Such misunderstandings may lead to mismanagement of their child's care. This past year at Children's Hospital Los Angeles (CHLA) we have had the challenge of providing culturally competent care to Arabic speaking families practicing Islamic traditions on the Pediatric Bone Marrow Transplant (PBMT) unit. As a health care provider it is our responsibility to provide adequate care by communicating eff ectively while also being culturally sensitive to all of our patients and families on the PBMT unit. Cultural competence is acknowledging the importance of culture in a person's life. Cultural competence is achieved by respecting cultural diff erences as well as minimizing any negative consequences of cultural diff erences. To increase our understanding of the Islamic faith and practices, we have utilized a multidisciplinary approach to education and support, and as a team have become more culturally competent. Nurisng care plans for each patient have been developed to educate staff in how to provide culturally sensitive and respectful care to the patients and their families.
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A weekly conference is scheduled between the team and families. This conference provides medical updates and opportunities for families to ask questions and express concerns to the multiple disciplines present. Spiritual Care Service provides culturally sensitive support to our families as well as educates our staff about the Islamic culture and traditions helping our staff become more competent health care providers. Language/Diversity Service is able to secure licensed medical interpreters to ensure that information is appropriately conveyed to our families whom do not speak English. Clinical Social Work is present to provide culturally competent support to the famlilies as well as to represent each family's unique voice to the medical team throughout treatment. On the CHLA PBMT unit we have found by utilizing a multidisciplinary approach to education and support, we are able to deliver not only family centered but also culturally competent care to our Islamic patients and their families.
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Impact of thrombotic complication on central venous catheter function D Venslauskaite, V Staponaviciene, J. Rascon, S. Stankeviciene, L. Rageliene Children's Hospital, Affi liate of Vilnius University Hospital Santariskiu Klinikos (Vilnius, LT)
Background: Chemotherapy and HSCT is impossible without placement of central venous catheter (CVC). Thrombotic complications are one of the main reasons of CVC occlusion that leads to CVC removal. A CVK is an expensive device; moreover insertion of a new line can cause intraoperative complications. Therefore prevention of CVC-related thrombotic complications is essential for minimization treatment related complications. Aims: We aimed to evaluate frequency of thrombotic complication among patients treated for hematologic malignancies with or without HSCT and to assess their impact on the rate of CVC removal. Methods: Functioning of CVC was prospectively assessed in 50 children (median age 7,7 years, range 1-16 years) receiving chemotherapy with or without HSCT for leukemia/lymphoma (37 pts.) and solid tumors (13 pts.). Perfusion of each CVC line of every patient was daily recorded by nurses in a special chart from 1st May 2012 until 1st November 2012. Results: Totally 51 children were evaluated: 5 Hickman, 19 Porta-cath, 5 CVC inserted in v. subclavia (Figure 1 ). All single-lumen lines (3 Hickman and 19 Port-a-cath) were transient during the study period. In eight of 24 (33%) double lumen Hickman lines at least one lumen occluded (Figure 2 ). In three of 8 both lumens became intransient that caused CVC removal. Totally 3/27 (11%) of double lumen Hickman lines were removed. Two-lumen CVC inserted in v. subclavia (CVCs) were non-problematic. In 1/3 three lumen CVCs occlusion of one lumen occurred, in the remaining 2/3 -two lumens became intransient. However none of CVCs was removed prematurely. Conclusions: Totally 3/51 (6%) were removed due to thrombotic complications. No thrombotic-related CVC occlusion occurred in single-lumen catheter that probably could be explained by most intensive perfusion.
P1373 Extracorporeal photopheresis in combined immunosuppressive therapy of teenagers and young adults with steroidrefractory acute graft-versus-host-disease O. Ivanova, T. Vikulina, M. Mihailova, A. Kozlov, T. Bykova, M. Estrina, L. Zubarovskaya, B. Afanasyev R.M. Gorbacheva Memorial Institute of Children Hematology and Transplantation (Saint-Petersburg, RU)
Objective: The objective of the study was to assess the eff ectiveness of extracorporeal photopheresis (ECP) in teenagers and young adults (TYA) with acute graft-versus-host disease (aGVHD). Methods: ECP was used as treatment option in 18 TYA with steroid-refractory aGVHD (grade II (n=7), III (n=4) or IV (n=7)). Skin was aff ected in 15 of 18 cases, gut in 4 and liver in 2. The diagnosis of aGVHD was confi rmed by histology whenever clinically indicated. All patients (pts) received ECP as a component of complex immunosuppressive therapy: combinations of calcineurin inhibitors/steroids/ECP in 5 pts, calcineurin inhibitors/steroids/MMF/ ECP in 6 pts, calcineurin inhibitors/steroids/monoclonal antibodies/ECP in 5 pts, and calcineurin inhibitors/steroids/monoclonal antibodies/MMF/ECP in 2 pts. Treatment protocol consisted of 1-2 procedures per week and varied individually depending on patient tolerance and response. Median number of procedures was 5 and median duration of treatment was 1 month. ECP procedure was conducted using an offl ine system. Apheresis was performed with Spectra Cobe cell separator. Collected mononuclear cells were incubated with 3 ml of 8 MOP so that fi nal concentration of 8-MOP was 200 ng/ml. UV Illuminator Macogenic (MacoPharma, France) was used for UV-A irradiation. Irradiation dose was 2 J/cm 2 if hematocrit of fi nal product was less than 3% and 2.5 J/cm 2 if hematocrit of fi nal product was higher than 3%. Then the product was returned to the patient by reinfusion. Average duration of the procedure was 3 hours. Results: Overall response to ECP was observed in 11 pts (61%), partial response was observed in 8 pts (44%) and complete response in 3 pts (17%). With a median follow-up of 165 days (range 53-945) after allogeneic hematopoietic stem cell transplantation 6 of 18 patients (33%) remained alive. Causes of deaths were aGVHD progression in 4 pts, infectious complications in 5 pts, thrombotic thrombocytopenic purpura in 1 pt and relapse in 1pt. Conclusion: Though, ECP in TYA with steroid-refractory aGVHD is associated with high rate of response it does not result in high long-term overall survival.
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The 'decision making fl ow chart' in blood marrow allogeneic transplantation
C. Dall'Olmo, L. Orlando on behalf GITMO
The decision making process in allogenic blood marrow transplantation is often complex and problematic, because it doesn't implicate only clinical assessment but also ethical and deontological evaluations, and it ultimately depends of patient's choise. Objectives: The object of this work is creating a "decision making fl ow chart" that could help physicians and nurses understand if it S493 is worth for a specifi c patient to undergo allogenic transplantation, a lifesaving procedure with many risks and side eff ects. Methods: A literature review leads to evaluate all the aspects implicated in the decision making process, especially in the ethics and deontological topics, in order to fi nd which are the conditions that make a physician decide for transplant procedure and a patient to decide to accept. Results: There are two basic indications for decision making process: a clinical assessment and an ethical evaluation. The clinical assessment is a physician competence, but it should also belong to the nurse evaluation, due to close contacts between the nurses and patients. The ethical and deontological evaluation is not only about the procedure in itself, but also on the others aspects such us the quality of life evaluation, psicological and emotional factors, analysis of the social, familiar and cultural context. In both cases when choosing the transplant procedure, it's necessary that the advantages and the benefi ts outweigh the risks. Others two factors are necessary in order to undertake a transplant procedure: fi rst, the availability of donor; second, the economic sustainability. But the essencial element on which the fi nal decision is taken is the patient because he ultimately acconsent to the procedure. Conclusion: The free patient's choice, that is the crucial element in the decision making process in allogenic blood marrow transplantation, is the fi nal step of a long journey, where it's necessary to evaluate the clinical situation and the ethical conditions, and to make sure of the donor is really available and the transplant can be performed economically. Findings: G-CSF + Plerixafor mobilization regimen ensured adequate HSC yield for all patients to proceed to transplant following one mobilization. In the group harvested with G-CSF-only 20% required multiple harvests. Plerixafor was well tolerated: 2 patients had grade 3 -4 diarrhoea,1 patient complained of fl ulike symptoms for 24 hours. Median time to engraftment post ASTC was the same for both groups at 12 days.
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Filgrastim in patients after autologous stem cell transplantation H. Svabova, A. Zmijakova, M. Zitkova University Hospital Brno (Brno, CZ) Aims: Granulocyte-colony stimulating factors (G-CSF) are a standard of care in patients after autologous hematopoietic stem cell transplantation (ASCT) to support white blood cell (WBC) count recovery. In 2010 we decided to incorporate pegylated fi lgrastim (pegG-CSF) into routine use. The aim of this analysis is to evaluate the impact of pegG-CSF compared to G-CSF to a shorter length of neutropenia, hospitalization stay, incidence of infection and quality of life after ASCT. Methods: Two groups of patients treated with ASCT for lymphoma or multiple myeloma were followed up. Group A with pegG-CSF was analyzed prospectively in comparison to a historical cohort (Group B) of patients with G-CSF. Results: One hundred and forty-seven patients were included in this analysis, 52 with lymphoma and 95 with multiple myeloma. Group A comprised of 77 patients where one injection of 6mg pegG-CSF was administered (at day +1 or at WBC count less than 2.0G/L) between 2010 and 2012. Seventy-seven historical patients in Group B received 5ug/kg G-CSF daily (from day +7 until WBC count above 2.0G/L) between 2006 and 2011. PegG-CSF led to a shorter duration of neutropenia and a shorter hospitalization stay. We cannot prove a lower rate of infectious complications. Conclusion: According to our analysis we can conclude that pegylated fi lgrastim given in a single dose after autologous hematopoietic stem cell transplantation has a superior eff ect on leukocyte engraftment as well as on the length of hospitalization compared to daily dose of fi lgrastim in patients with lymphomas and multiple myeloma. Moreover, administration of a single subcutaneous injection is much more comfortable for the patient and the nursing staff .
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Extracorporeal photopheresis: treating low body weight and low haematocrit patients T. Maher, M. Foster, R. Whittle, H. Denney, R. Goodgrove, C. Swift, F. Hammerton, L. Robertson, J. Mayo, A. Alfred, P.C. Taylor Rotherham Foundation Trust (Rotherham, GB) Introduction: Rotherham Foundation Trust is the fi rst UK hospital to treat paediatric patients with chronic Graft versus-Host Disease (cGvHD) with Extracorporeal Photopheresis (ECP) using the Therakos Cellex(TM) integrated photopheresis system. ECP consists of drawing anticoagulated venous blood from the patient into the photopheresis machine where it is separated by centrifugation. Red cells are returned and a mononuclear rich leucocyte fraction is collected. These leucocytes are treated with methoxsalen solution, exposed to UVA light and then returned to the patient. Patients receive repeated treatments over a number of months. In-treatment fl uid balance management of a patient is critically important. A key factor in preventing hypovolaemic faints is to ensure that the extracorporeal volume (ECV) does not exceed 15% of the patients total blood volume. Until recently, ECP in the UK has been limited to patients with a body weight above 40kg, as ECV may exceed 15% in lower body weight patients. Methods: The device manufacturer's guidelines detail the estimated ECV relative to the heamatocrit. For example, it identifi es that a patient of 19.65kg with a haematocrit of 32% would exceed 15% ECV. A blood prime is therefore indicated to safely treat the patient without extracorporeal loss. The blood prime procedure is used for a patient with a low haematocrit and / or body weight using cross-matched compatible packed red blood cells to prime the centrifuge bowl of the Cellex(TM) device, before drawing blood from the patient, thus minimising the ECV and maintains a static fl uid balance. Results: Our experience of utilising the blood prime procedure for low body weight and low haematocrit patients indicates a low risk profi le. Treatment planning is key to success to ensure compatible blood is available. The blood prime procedure has thus far facilitated ECP treatment of patients as young as 2.8 years and as low as 18.5 kg in weight. Median circulating blood volume processed during 280 low body weight treatments was 900mls which compares favourably to non-blood prime, adult procedures. Data review demonstrates that 2 blood prime treatments have been performed for low haematocrit patients during a 2-year period which have prevented ECP deferral. Discussion: The use of the blood prime procedure has allowed our service to expand to the inclusion of low body weight / paediatric patients and has reduced the incidence of treatment deferral due to low patient haematocrit.
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Nursing care of the child undergoing a thymic transplant K. Snell, A. Fillingham, L. Brown Great Ormond Street Hospital (London, GB) Aims and objectives:
• Standardize the care given to thymic transplant patients.
• Educate and raise awareness of thymic transplants. Thymic transplants are a new treatment within our unit and with this came unexpected nursing challenges that prompted a review of the nursing care given in order to standardize the care for future patients. We sought to undertake a review of the six patients who have undergone a thymic transplant procedure at Great Ormond Street hospital; we then used the knowledge gained to devise a nursing protocol to standardize the nursing care given to these patients. Background: Di George Syndrome is a genetic primary immune defi ciency. Features include; Heart defects, endocrine complications like hypocalcaemia, hypoparathyroidism and hypothyroidism, dysmorphic features, Cleft lip/palate and an absent or small thymus gland. Patients that need Thymic Transplants are those who are born without a thymus gland. The Thymus' function is to turn very immature T cells into naive T cells with a purpose and educates the T cells to recognise 'self from non self' . Without functioning T cells, the patient's immune system cannot fulfi ll its role. Our review aims to share the challenges experienced with this cohort of patients and to share the nursing protocols we have developed, highlighting the lessons we have learnt. Numerous complications were identifi ed throughout the patients' journey which led us to focus a care plan around specifi c care required such as airway management for those patients who have tracheostomys, wound management post surgery, infection control, discharge planning, pain management and patient and family education. Our aim is to streamline the journey of this complex group of patients.
P1379 Ambulatory care for the teenage and young adult transplant patient; implications for practice B. Ingram, M. Wall, L. Brown, R. Sohal University College London Hospitals (London, GB)
The Teenage and Young Adult Ambulatory Care (AC) Unit at University College London Hospital cares for patients aged 13-24years of age. Due to advancements in supportive medications and new portable infusion pumps, Ambulatory Care can provide cancer treatments in an outpatient setting, historically being delivered on an in-patient ward. This includes transplant regimes. TYA AC has successfully treated sarcoma patients receiving high dose chemotherapy and autologous stem cell transplantation. Eligible patients visit our AC Unit daily, where they are reviewed by their transplant team and receive treatment. While patients are clinically well, they reside in a near by 'Home from Home' or Patient Hotel. An in patient bed is reserved on the ward for all AC patients. Aims: Ambulatory care aspires to promote the choice and control teenagers and young people so often lose on diagnosis and during intensive treatment. Ambulatory Care promotes independence, empowerment and peer support. It allows TYA's to negotiate responsibility with their clinical teams, family and friends. Methods: Patients are educated and assessed regarding safety and self-management whilst ambulating. This may involve maintaining a fl uid balance, monitoring infusion pumps, selfadministering oral medication, and knowing when to seek medical help. Patients receive their conditioning regimens within the AC unit, and were discharged each day with backpack hydration systems. The patients receive the stem cell infusion within AC and remain there if well until elective ward admission is required. Results: 2 patients have received their conditioning regimes this way. Saving a total of 14 nights stay in hospital. Both patients were admitted day 0 following stem cell return, which was either a clinical or patient decision. Implications: Chemotherapy conditioning regimes, stem cell infusions and supportive medications has been safely and successfully delivered in the AC setting, off ering an alternative to an inpatient stay for some teenagers and young adults. To ensure safety, AC nurses pre-emptively approach patient management ensuring patients are admitted safely and appropriately. A comprehensive assessment tool supports this. Nursing staff , have become aware of the potential shift in responsibility from the AC team to the patient or companion.
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The role of the medical assistant in the stem cell transplantation process
S. Novakovic, G. Nair, E. Aerts University Hospital Zurich (Zurich, CH)
At the University Hospital Zürich, Hematopoietic Stem Cell Transplantations (HSCT) have been performed for more than 36 years. For some patients with a hematological or oncologic disease, stem cell transplantation is their only hope for a cure. In treating a patient by stem cell transplantation practitioners from diff erent medical areas are involved. The purpose of this essay is to explain the role of Medical Assistants working in the outpatient clinic in the HSCT process. Being diagnosed with a hematological/oncologic disease is a severe shock for most patients. Some need immediate treatment; others can live years without any symptoms. As soon as transplantation is given as an option, the physician will explain to the patient the risks and possible outcomes of HSCT. The Medical Assistant is responsible for scheduling this important meeting. If the patient is found to be a suitable candidate for this treatment and agrees to undergo an HSCT, the next task of the Medical Assistant is to ensure that all tests that are needed are carried out. The patient will then visit the stem cell transplantation ward and be given practical information on the procedures involved in this treatment. After the patient has been discharged he or she still requires regular check-ups. These involve a physical examination, blood tests to check for any signs of Graft-versus-Host-Disease and tests for other complications that may occur including the possibility of relapse. The role of the Medical Assistant in the post transplantation phase of HSCT is to take the blood samples, give injections and infusions and assist with bone marrow/lumbar punctures. The interval between examinations can be extended to yearly follow-ups if the patient shows signs of a sustained recovery. The work of the Medical Assistant in this case is to provide secretarial services such as scheduling appointments, answering any requests for information, writing medical reports and updating patient fi les.
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Conclusion: Medical Assistants are involved in a wide range of clinical activities, which are pivotal to the treatment of HSCT. The Medical Assistant makes a diff erence by being the centralized point of co-ordination in today's hospital environment; in so doing Medical Assistants optimize all the diff erent aspects involved in the delivery of optimal care to our patients and their relatives. Introduction: Haemato-oncological patients can suff er from vaginal dryness causing itching, burning irritation and pain, and as a result sexual activity can be compromised. Despite the various safe and eff ective options, only a minority of the patients will seek help. Aim: The purpose of this presentation is to present a tool in which basic information on the diff erential diagnosis can help to start an eff ective intervention for the treatment of vaginal dryness. Methods: Relevant published literature was used to identify the etiology for vaginal dryness in haematological female patients. Non-hormonal lubricants and moisturizers were tried out by the authors themselves to be able to fi nd the most suitable products. Results: In haematological patients vaginal dryness can be caused by diff erent reasons, e.g. premature ovarian failure or postmenopausal women, Total Body Irradiation, alkylating agents, neurotoxic agents, fungal, viral and bacterial infections, and (genital) Graft versus Host Disease. Handing over a vaginal lubricant is not enough as each cause needs a particular intervention: Hormone Replacement Therapy in premature ovarian failure, local vaginal estrogens in postmenopausal women, and in case of irradiation of the pelvis. Non-hormonal lubricants or moisturizers are indicated for ongoing vaginal dryness, itching or burning sensations or dryness during sexual activity. Conclusion: Women should be informed of the potential benefi ts and risks of the treatment options available, and with the help of their healthcare provider, choose an intervention that is most suitable to their individual needs and circumstances.
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P1382 CD-Rom as a tool for responding to patients' concerns before and after autologous stem cell transplantation D. Issarni CHU (Nantes, FR)
Autologous stem cells transplantation (auto-SCT) is the treatment of choice for many patients with hematologic malignancies, especially myeloma and lymphoma. Beside the medical aspects, the success of auto-SCT involves a complex logistic, and requires a specifi c organization before performing the procedure itself. The role of transplant coordinators was already proved to be of crucial importance to implement and ensure the correct performance of auto-SCT beginning with the decision taken within the multidisciplinary meeting, until admission of the patient. The transplant coordinator missions include logistical considerations regarding the timing of venous central catheter introduction, stem cells mobilization and collection, pre-transplant work-up organization, planning for hospitalization and for graft infusion after conditioning regimen. Besides these practical considerations, other specifi c and important concerns have been expressed by patients regarding their supportive care, medication regime, quality of life, care and rehabilitation during and after auto-SCT. As patients' expectations are very high, we thought to develop a specifi c tool in order to provide constantly suffi cient information to our patients. Indeed, we decided to create a CD Rom where the whole auto-SCT process is described precisely with answers to the most frequently asked questions. The creation of this communication tool involved a multidisciplinary work that allowed to gather a comprehensive set of information provided in the CD Rom. The content of the CD-ROM will also soon be available on the hospital's website to allow for a broader access to information. We are currently working on the indicators that would allow us to evaluate the potential of such initiative.
P1383
Patient and staff knowledge of optimal diet after stem cell transplantation: how to do better? B. Stéphanie, F. Maria, T. Marie, C. Catherine, D. Claudette, B. Laetitia, L. Christel, L. Véronique, D. Ines, M. Michèle, R. Maryvonne, L. Nadine, D. Valérie, P. Cécile, C. Catherine Henri Mondor (Créteil, FR) Introduction: Following allogeneic haemotopoietic stem cell transplantation (SCT), patients are at risk of malnutrition secondary to multiple causes: modifi cation of appetite, taste loss, and food aversions. Additionally, gastrointestinal GVHD is often associated with weight loss and considerable limitations of oral food intake.Objectives: To identify the main problems encountered by patients for oral food intake after SCT, to elaborate recommendations consistent with taste changes, and evaluate staff knowledge about low-microbial diet food. Methods: A working group was designed in 2012 on the basis of these objectives and included 11 members among dieticians, nurses, auxiliary nurses and physicianss. A semi-structured and qualitative questionnaire was distributed to 34 members of the haematology ward (57% of the day working staff ) to know about the level of knowledge of the staff . A second questionnaire was proposed to 20 SCT recipients followed in our outpatient unit. Results: All the patients were given oral, detailed instructions about low-microbial diet before discharge but only 70% received a written explanatory note. Twenty percent of them did not receive additional informations about specifi c diets, such as diabetes diet for patients under steroids. Consequently, 61% of the patients had problems with self-management of nutrition and still needed to have clarifi cation on some food issues, especially what spices to use in cooking and the kind of bread allowed for consumption. As for the staff , the survey showed that the level of knowledge was not optimal: 21% of the participants did not give accurate answers on several questions. Standardized instructions seemed to be given to the patient via several interlocutors and 39% of the participants might not take suffi cient time to explain clearly all the issues and answer the patients' questions. Conclusion: On the basis of these surveys, considering that our way to give recommendations about diet to SCT recipients was not optimal, we have reinforced the training of the staff members on this issue in collaboration with the dieteticians, and developed a specifi c program of nurse consultation, both at discharge and in the outpatient unit.
P1384 Information for pre-BMT partients: a cross country inquiry A Berthelsen, L. Pedersen Rigshospitalet (Copenhagen, DK)
Background: As transplant coordinators we have the fi rst contact with all Bone Marrow Transplant (BMT) patients referred to our unit. Our experience is that the patients have a lot of questions concerning transplant. Initial information about BMT is given at a diff erent hospital, by physicians/nurses who are not specialized in BMT. Purpose: To fi nd out what information is given to the patient from diagnosis until being admitted to the transplant unit , what information is needed from a patient, doctor and nursing perspective and how should it should be given. Method: We created a semi structured questionnaire and emailed it to eight doctors and nurses at fi ve referring hematology units in Denmark. All agreed to participate. Seven interviews were carried out over the phone and one in person.
We handed out the questionnaire to eight patients who received their transplant during September /October 2012. All patients agreed to participate. Patients were interviewed in person at the hospital clinic. We also conducted two focus group interviews among nurses in the in-and outpatient BMT-clinic. Results: All participants stated that they would like more information about time range from diagnosis to the time of transplant. It is diffi cult to have the full view of time frame from HLA typing is performed to the time of transplant. The patients stated that lack of time frame makes them and their family frustrated since there are economic, work related, and social arrangements to take care of before the transplant. Information could be carried out as a small pamphlet. All patients and a couple of staff from referring units asked for more visual information; video with patients going through the transplant period, pictures of the transplant unit. Some asked for a list with links to web pages about BMT and a list with frequently asked question (FAQ) given at the time of HLA typing. One of the patients suggested that staff from the transplant unit should go to referring hematology units to teach staff . Perspectives: To establish collaboration with the Danish Cancer organization to produce a video about what happens before, during and after a BMT. Create information material that the doctors and nurses can give to the patient at an early stage. Arrange visit/meetings with referring hematology units, teaching staff .
P1385 Family training on central venous catheter management after gene therapy treatment
M. Casiraghi, M. Palumbo, F. Fraschetta, S. Darin, R. Tresoldi, A. Ciceri, A. Biffi , M.P. Cicalese, F. Ciceri, M.G. Roncarolo, A. Aiuti, C
. Soliman San Raff aele Scientifi c Institute (Milan, IT)
Background: Over the past 15 years the Pediatric ImmunoHematology Unit at San Raff aele Hospital has focused its activity to diagnosis and treatment of patients with rare genetic diseases by allogeneic hematopoietic stem cell transplantation and gene therapy. Today, two trials are running to cure children coming from all over the world suff ering from rare genetic diseases, including the Wiskott Aldrich Syndrome (WAS) and the Metachromatic Leukodystrophy Desease (MLD). A long term Central Venous Catheter (CVC) implantation is required to permit therapies administration, transfusions, drawings and experimental drugs infusion. The nursing care includes the parents' health education to the CVC management during the follow up time before returning home. Aim: The objective is to provide to the parents the knowledge and the abilities necessary to guarantee a correct CVC management: daily evaluation of the insertion site, problems report to the medical-nursing staff , periodically dressing change and simultaneously check of the lines. The adequate CVC management reduces the infection and occlusion risks related to the long term length. Method: The training is necessary for those families with socioeconomic and geographic distress: lack of medical equipment, absence of means of transport and the extreme distance between the domicile and the hospital. The educational process includes: verbal explanation of theoretic contents, basic passages demonstration, support through the complete execution, supervision during the independent complete execution and fi nal evaluation. These phases are repeated several times till the achievement of management autonomy. Results: This experience was realized with 7 families: 6 tunnelled CVC and 1 Port-a-Cath. At the end of training, the parents proved to understand the most important information regarding the prevention of infections through the dressing independent management. The nursing staff provided the illustrative materials for devices recommendation translated in the languages of their country of origin.
Conclusions: The educational process allowed parents to became competent in CVC management with reduction of economic and logistic uneasiness. The nurses increased their skills in educational content and had the opportunity to confront with diff erent sociocultural people. The families feed-back was positive and their direct involvement improved the quality and the safety during the global care supplied from the multi-disciplinary team.
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Establishing a manual for bone marrow transplant recipients and their relatives/caregivers in a new bone marrow transplant unit of the Hospital Sírio Libanês in Sao Paulo, Brazil R. Santos, E. Hirose, C. Carlos Cunha, S. Ferreira, L. Malavolta, M.Z. de Aquino, J. Ramos, L. Tucunduva, A. Gomes, C. Souza, L. Cristofani, A. Domingues, M. Serpa, T. Puschiavo, A. Mello, E. Fregnani, A. Nesrallah, C.A.R. da Silva, Y. Novis, V. Rocha Hospital Sírio Libanês (Sao Paulo, BR) A new Bone Marrow Transplant (BMT) Unit of Hospital Sírio Libanês (HSL) (EBMT: CIC 211) was opened in August, 2011. To structure the BMT unit, it was necessary to establish procedures and educational guidelines for the training of the multi-disciplinary team and the development of a Patient/Relative/Caregiver Orientation Manual. Objective: The aim of this project is to develop a Patient/Relative/ Caregiver Orientation Manual with the objective of providing a supportive tool for BMT patients and their relatives and caregivers. They would be able to refer to this Manual to obtain information regarding all steps of their treatment, from the pre-transplant period through the in-patient stay, discharge, and out-patient visits post-transplant. Methods: From September, 2011 through October, 2012 we held weekly meetings with the multi-disciplinary team focus on the care of BMT patients, collecting information about nutrition, physiotherapy, infections, supportive care (central line catheter), psychological aspects, doubts, logistics, and hospital infrastructure. In addition, we reviewed the literature relevant to the topic of our study. Also, we have adapted the Patient/Relative/Caregiver Orientation Manual according to the Hospital Sírio Libanês Institutional Manual. Results: We performed a total of 55 transplants (26 autologous, 12 allogeneic related, 4 haploidentical and 13 unrelated allogeneic) during this one year period. Using the collected information cited above, we were able to develop a Patient/Caregiver Orientation Manual. The Manual includes information about the BMT unit, the multi-disciplinary team (including comprehensive information about the role of each professional), details about the pre-transplant process, in-patient period (i.e. exams, dietary information, the actual transplant, infections, etc...), discharge information, and post-transplant guidelines (i.e. outpatient visits). Conclusion: A Patient/Relative/Caregiver Orientation Manual is an important tool to guide BMT patients because it provides detailed information about all steps of the transplant process, allowing the patients and their relatives/caregivers to have a better understanding of their care and reducing their anxiety about the transplant. We have just implemented the use of this Manual, and our aim in the future is to collect data to evaluate its effi cacy and eff ectiveness.
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Daily assessment form for acute graft-versus-host disease and veno-occlusive disease A. Kruecharn, S. Sasinil, J. Kaewanee, R. Yoshaung, M. Kamchom, N. Prasertsang, S. Wuthijaroonpan Faculty of Medicine Ramathibodi Hospital (Bangkok, TH) Acute graft versus host disease (GVHD) and veno-occlusive disease (VOD) are common complications after hematopoietic stem cell transplantation (HSCT). These complications cause suff ering or even death during the early course of HSCT. Instead of only taking care of patients with these adverse events, we aimed to help them receiving early diagnosis. Because of careful monitoring and early diagnosis and treatment may reduce severity and improve outcome of GVHD and VOD. Therefore, we developed a daily assessment sheet for detection of early symptoms and signs of both complications. For GVHD, we recorded temperature, skin rash (characteristic and extension), nausea and vomiting, stool (characteristic and volume), abdominal pain (pain score assessment), and jaundice. For VOD, we recorded body weight, abdominal circumference, intake/output, and jaundice. Before implementation of this data record form, we performed 13 allogeneic HSCT in children in 2010(11 related and 2 unrelated donors). There were acute GVHD grade 2-4 in 8 cases (61%) and mild to moderate VOD in 7 cases (53%). We have used daily assessment form since January 2011. Between January 2011 and 2012, we performed 20 HSCT in children with malignant and non malignant diseases (14 related and 6 unrelated donors). We could early detect acute GVHD in 10 cases (50%) and VOD in 8 cases (40%). The severity of acute GVHD was only grade 1-2 and VOD was mild. All patients completely resolved before discharged home.
In conclusion, we found that our daily assessment form for acute GVHD and VOD was a useful tool for early detection and minimized severity of these common complications. This could reduce hospital stay and cost of treatment as well as improve patients' quality of life.
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Establishment of platelet donor registry dedicated to the paediatric haemato-oncology department I. Porat, R. Ofi r, M. Ben-Arush, I. Zaidman, L. Bonstein Rambam HealthCare Campus (Haifa, IL) Children with malignant diseases undergoing, BMT are treated with intensive chemotherapy and suff er from protracted thrombocytopenia and hence, prolonged transfusion dependency with the rising risk for transfusion-associated reactions. In our hospital the default sores of platelets for transfusion are Post-storage, Pooled, whole-blood-derived platelet concentrates (PC) from 2-6 units of platelet-rich plasma donated by random donors. This is largely because of their lower cost compared to single donor platelets (SDP) by apheresis. It has been previously shown that Platelet transfusion with PC has higher incidence of alloimmunization, septic reactions and transfusion frequency in patients with BM suppression. On the other hand, SDPs off ers major advantages over PC for most of these issues, particularly when improved patient care is given primary emphasis. Cost evaluations showed that in-house collection of SDPs can be cost eff ective .This work describes the establishment of our department's donor registry dedicated to the collection of SDPs for our sick children.The fi rst step was the establishment of a coordinating group including physicians from our pediatric hematology department, a nurse BMT coordinator and the director of the blood bank acting as the SDP project manager.The recruitment process parallels the decision for transplantation and includes:Explaining the process and its importance to the parents by a conversation with the family,Determining ABO type of platelets needed in consideration with both the patients and donor blood types,Locating potential donors by the family with the assistance of the coordinating nurse, Completing compatibility Blood tests for the donors including blood counts and viral screening, Scheduling collection dates for eligible donors in accordance with the child's needs and in collaboration with the apheresis unit.Over the last year, 258 units of SDPs were collected. Children undergoing allogeneic BMT, who received SDPs as a sole source of platelets needed an average of 6-7 platelet units during their recovery, compared to an average of 12-14 pools of random donor platelets. In addition, Children receiving SDPs suff ered from signifi cantly less adverse transfusion reactions and showed signifi cant higher platelet increments. Besides its clinical signifi cance, this process of recruitment gave the families an opportunity to help by platelet donation, creating a sense of partnership and contribution to the child's recovery P1389 Epidemiololgy and foci of bacterial infections in patients after allogeneic haematopoietic stem cell transplantation G. Polupan, A. Bodanova, V. Osipchuk, Yu. Averianova, N. Bondarenko, V. Afanasyev Saint Petersburg's Pavlov State Medical University (Saint Petersburg, RU) Objective: Allogenous hematopoietic stem cell transplantation (allo -HSCT) patients develop immunodefi ciency. There are often no clinical manifestation of infection and the mark of severe infection is a fever. Estimating specifi c immune status and morphological damage of skin/mucosa severity of infection (local or disseminated) it is necessary to perform corresponding tests to reveal the pathogen. The aim of this research was to study the epidemiology and foci of bacterial infection (BI) in allo-HSCT-patients. Materials and methods: 175 patients with various oncological diseases were included in this research. There were revealed 956 positive seedings of BI pathogens. Bronchoalveolar lavage (BAL) and sputum were used to reveal BI pathogens of respiratory tract. Middle portion of urine or urine received with catheter was used to diagnose the urinary tract infection. The material to reveal ENT BI was the ear discharge and content of pararnasal sinus. The double sample serums received from central venous catheters\and peripherical vein were used to determine bacteraemia pathogens. Results: While analyzing structure of BI focuses there were sown pathogens most often in urine (43%), blood (22,5%), oral cavity (22,5%), BAL (7%). The main blood pathogen was S. epidermidis (31%). The main urine pathogens were Kl.pneumoniae (15%), E.coli (17%), Enterococcus spp. (30%). Among agents revealed in sputum and BAL there were Enterococcus spp., Kl. pneumonia, Ps. Aeruginosa, all in the same proportion (12%). In the oral cavity and pharynx there were revealed Gram-positive and Gramnegative microorganisms. Conclusions: The main sources of BI were urine, blood, content of oral cavity, scutum and BAL. The most important pathogens were: S.epidermidis, Enterococcus spp., Kl.pneumoniae, E.coli, Ps.aeruginosa, Enterobacter spp. The nursing staff should know about BI problem in allo-HSCT-patients. Components of nursing process should be nurse examination, nurse diagnosis, treatment planning, execution of nurse intervention plan and judgment of results. Key words: bacterial infection, pathogens, infection focus, haematopoetic stem cell transplantation.
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How to improve self-reporting in female genital tract graft-versus-host disease? M. Steinbo, I. Thøstesen, F. Gossmann University Hospital Copenhagen (Copenhagen, DK) Objectives: Graft versus host disease (GvHD) is a common complication following allogeneic stem cell transplantation (STC), and studies show that up to 25% of the female patients experience vaginal GvHD. Vaginal GvHD and symptoms in the genital area due to hormone defi ciency are associated with poor sexual functioning and lower quality of life. Vaginal GvHD is often detected late, but similar to other types of GvHD early detection is important in order to successful treatment. In our clinical practice female patients do not that often report symptoms of vaginal GvHD or other symptoms, and we suspect this problem is under-reported. This might be due to poor interest and investigation from doctors and nurses and thus poor information is provided for the patients. We set out to examine how our female patients experienced information and guidance from the clinical staff concerning vaginal GvHD in order to improve our clinical practice. Method: A simple questionnaire was handed out to three female patients with previous or ongoing GvHD in the genital tract. The patients were selected in order to have moderate and severe GvHD represented. The purpose was to uncover if the patients had had any information on vaginal GVHD before and/or when symptoms emerged. The questionnaires were followed by informal interviews in order to get more detailed data of the patients' personal experiences and needs concerning information and how to observe and deal with vaginal GvHD. Results: All women were very keen to participate. All stated lack of information both before and when GvHD or other symptoms occurred. They had missed this type of information and felt left alone with their problems. Initially they did not relate the problems with STC and GvHD, thus they did not report it to the staff until later. Conclusion: The patients lacked specifi c information and guidance concerning vaginal GvHD both before and after onset, pointing out a need of changing procedures of information in our clinical practice. A pamphlet was made focusing on various kinds of symptoms related to the female genitals. The main purpose is to provide appropriate information for the female patients, and to support them in paying attention to symptoms and report these to the staff . The pamphlet also contains information of options for treatment and suggestions to alleviate symptoms. The pamphlet should be given to all female patients by a nurse and followed by oral information.
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Onco-haematologic patients' sexuality. What do you do? What do you know about it? M. Ruiz Seixas, M. Vázquez Móncada, J. Praena Fernández, F. Márquez Malaver, T. Gómez Férriz, J. Quijano Campos, J. Pérez Simón, L López Rodríguez Hospital Universitario Virgen del Rocio (Sevilla, ES) Onco-hematologic disorders and its therapeutic interventions heavily hamper sexuality, an important aspect with a great infl uence on overall health perception. Information and advice may help patients cope with sexual diffi culties and improves their quality of life (QL). There is a lack of information concerning the knowledge level (KL) and training of health care providers (HCP) to deal with patients' sexuality and dysfunction problems (SADPs) related to disease and treatment process. Aim: To determine the KL of HCP, and their attitude toward oncohematologic patients' SADPs. Methods: A cross-sectional study to evaluate the KL perceived was conducted among nurses and physicians from the haematology ward of a Spanish hospital, in January-2011. Results: Thirty-four HCP participated in the study (characteristics in Table#1). Overall KL perception was rated as good by 55.9% participants and low by 5.9% of them. Eighteen percent reported a good KL regarding sexual dysfunction which might aff ect patients while 42.4% qualifi ed as poor level. Fifty-nine percent of participants considered that they could properly address some complaints regarding patients' sexual dysfunction (Table#2). Forty-four percent reported to have a low KL about the eff ect of treatments on patients' sexuality. Ninety-seven percent of responders considered that sexual dysfunctions had a negative impact on QL. Ninety-one percent believed that it should be necessary to provide sexuality information to patients and 85.3% thought that it was part of their duties. However, only 17.6% included it in their daily practise. Eighty-two percent considered that they did not have accurate knowledge and 64.7% perceived that they were not highly skilled on this topic. Eighty-fi ve percent wanted to improve their KL and skills on SADPs, and 91.2% believed that increasing the training of professionals would help to improve patients coping with SADPs. Conclusion: Professionals believe that the KL about sexuality is good, but poor regarding sexual dysfunctions. Most professionals have not received specifi c training to deal with sexual dysfunctions. They believe that sexual dysfunctions have a negative impact on QL. Professionals also think that providing information about this topic is part of their duties, although they do not put them into practice. They want to improve their knowledge regarding sexuality patients' problems and believe that this would improve patients coping with problems related to sexuality.
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Improving patient experience on a stem cell transplant (SCT) ward E. Bautista, K. Bradley, O. Brokka Imperial College Healthcare NHS Trust (London, GB) As a result of a signifi cant vacancy factor, a major nursing restructure was undertaken that resulted in a successful recruitment campaign. However, this presented a new challenge as many were newly qualifi ed and/or inexperienced in the speciality. The development of the nursing team and individuals' skills, as well as, instilling the core values and vision of Imperial College Healthcare NHS Trust has been the focus in improving overall patient experience. Understanding and improving how patients experience their care is a key component to successfully delivering high-quality services that are based on their needs. Evidence demonstrates that better outcomes will be achieved when patient experience is a priority. It involves looking at every aspect of how care is delivered, including how the patient comes into contact with the 'health system' in the fi rst place. Experience is also determined by the physical environment patients are in and how they feel about the care they receive, including the way staff interacts with them. Improving patient experience starts by treating each of them individually to ensure they receive the right care, at the right time, in the right way. Some of the challenges are overcoming diffi culties with staff engagement in the patient experience audit process, embedding the patient experience survey tool (I-Track) into routine practice; long stay patients are reluctant to undertake repeated surveys that contributed to initial low submission rates. Engagement of staff was achieved through encouragement of new ways of thinking, re-instill core values of customer care, proper induction for all new nurses, improve communication within the team, re-defi ne the Nurse in Charge role, and ensure feedback on survey/audits is meaningful and constructive to staff to improve performance. This is an on-going process and has resulted in the recent adaptation of team nursing. The team is now meeting the agreed I-Track target response rates, and are proactively implementing system changes that support the delivery of safe, quality care that meets the needs of patients.
We continuously evaluate and refl ect on performance to improve our patients' experience. Clinical leadership is pivotal in infl uencing and driving best practice on the unit. Providing support and training to staff will improve the quality of patient care and ensure patient safety. Oncology and Hematology and Bone Marrow Transplantation (Haifa, IL) Objectives: Treatment of bone marrow transplant (BMT) patients is a complex process requiring numerous medical resources and effi cient cooperation among multidisciplinary staff members. Poor communication between care providers may lead to medical errors, aff ect patient safety and ultimately contribute to an adverse patient's outcome. To improve and optimize the quality of care in the BMT Unit we have applied the case management (CM) method, which is a care delivery model designed to coordinate and manage patient care across the continuum of health care systems. Methods: As part of the CM approach, the senior staff of the Rambam BMT Unit (BMTU) has developed special fl ow charts for patient management, called treatment maps, which presented sequence of choices and interventions typically followed during the treatment of specifi c patient conditions. The map was divided into three stages of hospitalization: pre-implantation, during transplant procedure and post-transplant period, including discharge. The CM model was presented at the nursing staff meeting and nurses were instructed on the use of the map in their everyday work. After 2 months of the approach application, all nurses and patients were asked to fi ll in the questionnaire evaluating their attitude towards the model implementation and infl uence on the quality of care. Data obtained from 39 nurses and 27 patients were analyzed. Results: Increased satisfaction was expressed by all the patients participating in the study. Patients and their families indicated that they received guidance, education, professional and emotional support through all stages of hospitalization and in the immediate post-discharge period. They emphasized their deeper involvement in decision making regarding clinical treatment. Improved patient compliance was observed. The majority of nurses considered that application of the CM model contributed to improvement in the quality of patient care. Diffi culties in the model implementation included: resistance of some nurses to more intensive workload, and problems in the integration of parttime nurses and those going on vacation in the demanded work sequence. Conclusions: Implementation of the CM model was found to signifi cantly contribute to the improvement in quality of care and patient satisfaction. Application of this approach should be expanded to the entire continuum of health care systems, including day care units. Introduction: A high quality venous access is, among others, a prerequisite for successful cancer treatment. In our conditions, the successful peripheral venous catheterization (PVC) represents one of the most frequently used options for the intravenous drug applications. The intervention of catheterization, including the length of the safe insertion, follows a standard nursing procedure based on the CDC recommendations, the manufacturer`s instructions and the clinical manifestations. Methods: Between April and May, 2012 a prospective monitoring study of 500 cases with inserted PVCs was performed in our clinic. The aim of this study was to explore the aspects associated with the application of these catheters. The data were processed by standard sumars statistics Results: The sample consisted of 64.2% of PVC patients with hemato-oncology diagnoses, 20.4% cancer patients and 15.4% patients with other diagnoses. The mean length of using the catheter was 4.2 days (median 4 days). The reasons for discontinuing the catheterization were uselessness in 56.6 %, lack of the system functionality in 27.4 %, regular PVC exchanges in 7 %, para-applications
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of drugs in 5.6% and infections in 3.4%. When assessing the phlebitis extent according to the Maddon`s scale, degree 0 was identifi ed in 83.4%, degree 1 in 8%, degree 2 in 5% and degree 3 in 3.6%. A statistically signifi cant diff erence was found in the length of catheterization which was fi nished for real reasons, as illustrated in Graph 1. The occurrence of complications associated with the anti-infl ammatory drugs applications was significantly higher (p<0.001) than in patients who were not applied anti-infl ammatory drugs. When assessing the extent of phlebitis according to the Maddon`s scale, the degree 0 was signifi cantly higher (p<0.001) in patients in whom chemotherapy was applied than in patients without chemotherapy. Conclusions: During our research, interesting and contributive information was found out, which is to be dealt with in futuree.g. the infl uence of the patients themselves on the length of catheterization and possible complications associated with catheterization are to be processed in greater detail. In practice, the limitations associated with PCVs must be also taken into account, including the decrease of the patient`s quality of life and the infl uence on the patient`s peripheral veins.
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Improving the standards of oral care on a haematopoetic stem cell transplant unit C. Kay, A. Foyle, F. Dalit, M. Shrestha, H. Lawas, V. Lam Royal Marsden Hospital (Sutton, GB) Oral problems are common following myeloblative haematopoeitic stem cell transplants. To manage these oral problems Quinn (2007) sees the baseline oral assessment as a key component of oral care although few nurses receive any formal training in oral assessment or oral care (Southern 2007). A retrospective audit was carried out on 10 post-transplant patients to establish whether nurses had performed oral assessments on the patients as set out in the trust's Oral Care Standard Operating Procedure (SOP). The following questions were asked Has the patient an oral assessment chart Was a baseline oral assessment carried out on day one of admission Was an oral assessment carried out daily. The results showed that 100% of patients had an oral assessment chart and a baseline assessment had been carried out. However, only 30% had documentation to show that an oral assessment had been performed daily during the patient's inpatient stay. Given this result it was decided that a programme of re-education should be carried out across the unit to ensure all nurses understood the importance of carrying out the oral assessment in this patient group. The unit practice educator carried out this project with the assistance of 5 nurses who had volunteered to help her. Initially the practice educator trained these 5 nurses in the following areas. Importance of using an oral assessment tool. How to examine the oral cavity, including a practical session. How to document the fi ndings using the trust's oral assessment tool. Following this training the nurses were given a training pack and requested that they carried out the training across the unit using the same format to ensure uniformity. Each of the nurses was responsible for training 10 nurses across the unit. Once the training had been completed a further audit was carried out on 10 post-transplant patients to establish if there had been any improvement in the documentation to show that daily oral assessment had been carried out. The results were very positive showing that following the training programme 100% of patients had had daily oral assessments carried out throughout their in-patient stay. It is clearly obvious that the training improved the standard of oral assessments. It is planned that this training programme be extended within the next 6 months to include nurses on the unit be re-educated in delivering routine oral care and managing the potential complications, including patient education.
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Satisfaction with nursing care in a tertiary haematology unit M. A. Amat, M.M. Eseverri, M. Reig, M.J. Ruibal, J. Serrano Hospital Universitario Vall D'hebron (Barcelona, ES) Introduction: Nursing care has evolved dramatically in the past 50 years. The evaluation of care quality by the users, has been taking great relevance and now it is one of the issues measured in our institution. Objectives: To determine the degree of patients´ satisfaction regarding nursing care provided in the hematologic unit of the Hospital Vall D'hebron (Barcelona, Spain) between 2011-2012 an to identify the issues to improve the quality of assistance. Materials and Methods: We performed a retrospective observational study, including all consecutive patients treated in our unit including those who underwent a hematopoietic stem cell transplant in our unit between 2011 and 2012. The main variable was the patient satisfaction with nursing care using the scale of satisfaction LOPSS 12. The data we analysed with the statistical program SPSS 20.0 ®.
Results: We included 134 patients (42% females) with a median age of 57 years (range 21-88). The most frequent cause of hospitalization was the administration of therapy (37%), followed by evaluation of disease at diagnosis (27%). Median length of hospitalization was 15.4 days. The most frequent diagnosis were Lymphoma (32%), followed by leukemia (17%), stem cell transplant (7%). The most commons symptoms during admission were (as Edmonton scale) were: lack of appetite (62%), malaise (62%), asthenia (56%) and nausea (25%). The patients´ satisfaction evaluation were: very satisfi ed 70%, satisfi ed 22.3% , little satisfi ed 6.9% and unsatisfi ed 0.8%. The most frequently items qualifi ed as "fully agree": They gave me useful advices (68%) and they helped me to understand my disease with (61%) The item less commonly qualifi ed as "fully agree" was: Slow to answer my calls in which a (10.2%). Conclusions: The satisfaction of patients admitted to our unit, with nursing care is reasonably high. The results show values very close to maximum satisfaction described by the LOOPS, as well as the percentage of maximum dissatisfaction is practically nil (0.8%). The fi elds that comprise the characteristics of the quality of nursing care collected by the 12 LOOPS include: communication, knowledge, empathy and effi ciency. According to the data obtained, the knowledge and the capacity to give useful advice from nursing has been highly valued. While we have observed that the calls answered has been worse valued, we believe that this may be due to the subjective perception of the patient from the waiting time in a time of need.
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Patient experience of undergoing a bone marrow examination EM. Hultén, E.C Ingefj ord, I. Gustafsson Sahlgrenska Unirversity Hospital (Gothenburg, SE) Bone marrow examination is used in the diagnosis of a number of haematology conditions, including leukaemia, multiple myeloma, lymphoma and anaemia. For many years, we have developed good routines in performing bone marrow examinations at the Haematology clinic. We take tissue samples of bone marrow which are obtained by bone marrow biopsy and aspiration. Every month we perform around 60 bone marrow examinations. The assistant nurse and doctor work closely as a team and our role is to inform the patient of the procedure, prepare and assist the doctor when taking the samples. In September 2011 a survey was done to evaluate the experience of undergoing a bone marrow examination with the aim to use this information to improve the care and wellbeing of the patient. During this period, 42 patients answered the questionnaire. It was clear that 80-90% where satisfi ed with the information before and during the examination and the care they received during the examination. More than half of the patients, 60%, felt nervous about the visit. Many of them where afraid it would hurt, because they had previous experience of this. Half of the patients found the examination painful (VAS >3) and 10% reported 9 or 10 on VAS. The results regarding anxiety and pain were disappointing. To improve this, we made some changes in the procedures. First, we changed the information letter. We recommend the patient to take painkillers like Paracetamol before the examination with the purpose to alleviate the pain during the anaesthesia, the sampling and when the anaesthesia has no eff ect any longer. To reduce the discomfort with the anaesthesia, we have introduced the routine of using a very thin needle to numb the skin. In October 2012 we received the results of the second survey in witch we have focused on anxiety and pain. During this period 41 patients answered the questionnaire. It clearly shows that patient's anxiety have been reduced by 21% and pain by 16%, according to VAS (<3). It turns out that 44% of the patients took Paracetamol before examination. The majority, 80-90%, of the patients remained satisfi ed with the information they received before and during the examination. Next step will be to improve the information letter. Even if most of the patients where satisfi ed with the information they received before coming to the clinic 56% missed the information about premedication. We will continue with annual surveys to improve patient's wellbeing and maintain good quality.
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Meeting the increasing demand for PICCs in clinical haematology: the Hammersmith Hospital experience J. Gururaj, J. Hitchcock, S. Thomas, D. Paul, O. Brokka, K. Bradley Imperial College Healthcare NHS Trust (London, GB) Peripherally inserted central catheters (PICC) are increasingly being seen as the device of choice for safely administering complex intravenous therapies including chemotherapy in the haematology care setting. The benefi ts of these devices include, but are not limited to providing long-term central venous access for delivery of treatments that can irritate or damage small veins; reducing pain and discomfort caused by repeated cannulation, reduction in overall operational costs, decreased reliance on interventional radiology resources, and reduced risk of extravasation incidents. Advantages include relative ease of insertion, long dwell time, low complication rate and increased patient comfort with the introduction of the modifi ed Seldinger Technique, which enables the PICC placer to gain upper arm access. Advances in technology and vascular access products have benefi ted both the patient and the PICC placer with dual lumen PICCs being increasingly used in place of Hickman central venous catheters (CVC). Data since 2010 supports a steady increase in PICC usage to provide central venous access for patients undergoing autologous SCT, as well as delivering complex chemotherapy regimens, anti-infective therapies and supportive therapies including parenteral nutrition. PICCs are also being considered as an alternative to providing central venous access in the event of a Hickman CVC related infection during allogeneic transplant. In 2010, 36 haematology patients had PICCs placed and 14% were for the SCT patients. This increased to 62 PICCs being placed in 2011 with 18% being for the SCT patients and this trend continues to increase for 2012 with 58 PICCs being placed over the past seven months with 26% being for the SCT patients. To meet this increasing demand as the benefi ts of PICCS in relation to infusional therapy are demonstrated and to address lack of capacity related to interventional radiology and limited availability of the hospital vascular access team, senior nurses from the haematology day care unit have taken on PICC insertion training to ensure there are suffi cient numbers of PICC placers available within the haematology department. An essential element of successfully implementing this PICC nurse-led service has been the collaborative working between the hospital vascular access and haematology nursing teams. The Care Quality Commission (2011) report that individuals who accessed care services emphasised to them the importance of services fi tting around their needs, recognising their individual requirements and treating them with dignity and respect. Measuring these points and the quality of care delivered is not a new initiative but the tools we use appear to be ever evolving. As a ward sister team at the Oxford Bone Marrow Transplant Unit we wanted to take the time to talk to patients and gain their personal feedback about our service rather than receive a report generated from a pre-set hospital generic questionnaire. Using a simple tick box sticker for patient notes we were able to demonstrate we had undertaken a 'Ward Sister Round' and this prompted conversation around the patients care and experience of the ward and service. Protected time to undertake this personal feedback has been the catalyst for a number of changes in our unit. 1. 'Who's who and what do they do' Poster-patients fed back continually that the uniforms and roles of all the diff erent ward personnel was overwhelming, commenting 'I don't know who to ask for what' . This prompted a poster design of key roles and a brief description of duties for each side room/bed space 2. Nutritional Assistant and supplementary food provisionhospital food came up continually as a big negative, not only the quality but the timings of the meals. Lots of the feedback demonstrated that patients weren't getting their nutritional needs met to a satisfactory level and this supported the bid for a nutritional assistant to support the service dietician. This role undertakes BD build up milkshake rounds, explores patient's likes/dislikes and assists in meal choices as well as making supplementary snacks. 3. Ward based blood fridge. Patient feedback told us that the delays in blood product delivery was an on-going failure. The hospital system meant that a simple transfusion could take hours to organise and administer. The facility of a ward based blood fridge would allow for a streamlined service from lab to ward removing the need for other resources such as portering services and allowing a more effi cient service delivery. Our experience of personalised/protected Ward Sister Rounds has been incredibly positive and the weight of patient feedback incredibly infl uential in making positive changes that meet patient need and individual requirements.
P1400
Diff erences between nursing care of patients treated with allogeneic versus haploidentical bone marrow transplantation C. Soliman, V. Matozzo, M. Brambilla, N. Clercy, D. Basile, A. Assanelli, C. Corti, F. Ciceri San Raff aele Scientifi c Institute (Milan, IT) Background: The Hematology and Bone Marrow Transplantation (BMT) Unit with the Pediatric Immunology-Hematology Unit and the Transfusion Medical Service started the preparation phase in order to request JACIE accreditation for the Transplant Program (TP). Today, the underway phase interests the sending of quality documentation. In 2011, as concern the allogeneic (allo) and haploidentical (haplo) transplants activity, the PT counted 40 allo and 18 haplo BMT. The nursing care for these patients is highly specifi c and is based on the Evidence Based Practice. Aim: The nursing care of patients treated with allo and haplo BMT is directed to prevention and treatment of early/ late eff ects of BMT: toxicity, acute/chronic graft versus host disease (GvHD), relapse and infections during the hospitalization and follow up. The nursing interventions are performed in respect of the procedures written according to the JACIE standards (immunocompromised patients care, administration of preparative regimens, transplantation, central venous access device care, blood products administration) in order to improve the quality system. Method: The nursing assistance is carried out through the logic of total care, the centrality of person and family during the treatment path. The nursing process starts from the identifi cation of patient problems (assessment), moves to the defi nition of the assistance priorities (diagnosis) and of the required interventions (plan and act) and ends with the measuring of the results (evaluation). Results: The process is proofed through the nursing records and evaluation scales, these allow the sharing of all information between the multidisciplinary team. The instruments used to perform the nursing care include the health education supported by the brochures containing the recommendation for the admission and the discharge. The nurses usually apply and update procedures, report mistakes and fi nd solution of clinical problems in joint setting. Conclusions: The nursing care of patients treated with allo and haplo BMT is based on the same principles. The diff erences regard the identifi cation of the risk rates to meet early/late BMT eff ects, due to the preparative regimes and immunosuppressive therapy and, consequently, the choice of the best interventions. The nursing process is the method to guarantee the cures with respect to the patients personalization needs and the procedures application permit to equal the nursing activity in order to guaranty safe assistance.
P1401
A supersaturated solution of calcium and phophate (Caphosol ®) for prevention of oral mucositis in paediatric stem cell recipients M. Hartmann, S. Wieczorek, H. Pichler, S. Matthes, W. Holter, C. Peters St. Anna Children's Hospital (Vienna, AT) Orointestinal mucositis (OM) is frequently encountered in children receiving high dose chemotherapy and/or radiation for stem cell transplantation. Not only a risk factor for life threatening infections due to disruption of the mucosal barrier, it is also responsible for prolonged hospitalization owed to severe pain requiring systemic analgetics or parenteral nutrition. The prevention and treatment of transplant-related OM in children depends on compliance and includes various approaches.
Caphosol ® (EUSA Pharma), a supersaturated solution of calcium and phosphate has been introduced as mouth rinse for prevention of OM in adults with promising results. To the best of our knowledge, no data have yet been reported for its use in pediatric patients.
We therefore assessed the feasibility of administering Caphosol ® mouth rinse in children > 5 years. Five female and 9 male patients (age: 5.8 to 28.3 years, median age: 12.0 years) receiving stem cell transplantation for malignant or nonmalignant diseases at our hospital were enrolled into a pilot study using Caphosol ® to prevent OM. Administration lasted from conditioning until OM resolved. The number of daily applications, adverse eff ects related to its use (nausea, vomiting, pain or paresthesia due to the mouth rinse) and the severity of OM were recorded. With extensive support from nurses, most patients were able to administer the mouth rinse accordingly. A median of 2.9 applications per day (range: 0 to 5) were used throughout a median of 28.5 days (range: 3 to 49 days). Three patients (21.4%) prematurely abandoned the mouth rinse due to extended nausea or vomiting (n=2) and intensive care treatment for respiratory failure not related to the mouth rinse (n=1). Side eff ects observed during the application period were nausea, vomiting and pain >grade 3 (>3cm on a 10cm visual analogue scale) through a median of 3.5, 2 and 5 days respectively. One patient experienced prolonged salty taste.
We conclude that Caphosol ® mouth rinse is a feasible and acceptable method to prevent chemotherapy or radiation associated OM in children > 5years. It was generally well tolerated and no major side eff ects were observed. However, randomized studies are warranted to clarify if Caphosol ® is superior to other strategies for prevention of OM in children receiving stem cell transplantation.
P1402 Advantages of the distress meter T. Nagtegaal, L. Smittenberg UMC Utrecht (Utrecht, NL)
Motive: The last distress meter was introduced in 2010, in the national oncological guideline. Detecting need for psychological care. In which the distress meter was recommended for the basal psychological care of adult patients. Question: Is the distress meter of value for the basal psychological care of stem cell transplantation patients on the policlinic? Method: The distress meter will be off ered to the patients at any time. The patient will be invited for a consultation with the nurse. The nurse distributes the basal psychological care together with the distress meter. If necessary the patient will be referred to a specialist. Results: The patient is prepared before visiting a consultation. The use of the distress meter gives direction for the content of the consultation. The distress meter helps the patient and the nurse with talking about the health perception of the patient. The consultation may help the patient to deal with the consequences of illness and treatment. Conclusion: The distress meter is an instrument which is easy to work with. The distress meter off ers structure for the psychological care by a nurse. By frequently evaluating the consultations, nurses gain knowledge about the physical and psychological issues which are present by patients of a stem cell transplantation. Recommendations for development By evaluating the distress meter as a tool within the process of care, methods can by developed that are useful by the distribution of equal care. Possible ideas are intervisie, questionnaires, and measuring instruments for specifi c problems.
P1403
Retrospective, monocentric analysis of the occurrence of undesirable eff ects associated with total body irradiation in adults S. Jana (1) Introduction: The total body irradiation (TBI) is a treatment modality within the multidisciplinary approach for allogenic transplantation of hematogenous cells. The patients who have undergone total body irradiation are at an increased risk of undesirable side eff ects. The most frequent undesirable eff ects include nausea, vomiting, anorexia, diarrhea, fatigue, oropharyngeal mucositis, dermal toxicity and venoocclusive liver disease. Our analysis was focused on the characteristics of undesirable side eff ects in adults who had undergone TBI and were treated according to the FLAMSA+RIC TBI/Cy protocol. Methods: This study included TBI patients treated by a single dose of 4 Gy between 2008 and 2012. All the data on the treatment were collected retrospectively from the health care records on patients from one department. The data were processed by standard summary statistics. Results: The analysis of acute undesirable side eff ects was performed in the total number of 100 patients >20 years old in whom TBI was performed within a preparatory regimen. The sample consisted of 54 men and 46 women. In the most cases, these were patients with the diagnosis of leukemia. Acute undesirable side eff ects were identifi ed in 85 patients, the average age being 48 (20;63). Cumulative incidence (CI) until the day 30 after TBI was found out in 62% patients diarrhea, 39% dermal toxicity, 29% anorexia, 18% vomiting, 13% oropharyngeal mucositis, 12% nausea, 12% fatigue, 12% venoocclusive liver disease, 8% pain and 2% psychical changes. When analyzing the dermal undesirable eff ects in greater detail, the average length was found to be 5.3 days; the average onset was on day 2.9 (0;11) after the TBI. The dermal changes were noticed in 39% patients, the most frequent combined defects were found on palms, soles and genitals (9% of all patients, 23.1% patients with dermal changes). Diarrhea usually occurred one day after TBI with the median of 4 (1;18) days. During the statistic procession, a statistically signifi cant diff erence (p=0,002) in CI diarrheas was found in women (78.3%) in comparison with men (48.1%). Conclusions: Within our retrospective research, a signifi cant occurrence of undesirable side eff ects was noticed. The undesirable eff ects identifi ed can be caused both by the TBI itself and by a combination of many factors which can include the preparatory regimen, the transfer of hematogenous cells, comorbidity and others, which are going to be explored in greater detail in future.
P1404
Oral cryotherapy for the prevention of high-dose melphalaninduced stomatitis in autologous stem cell transplantation S. Kim, Y. Cho, S. Park, S. Lee, M. Jeon, K. Lee Asan Medical Center (Seoul, KR) The purpose of this study is to determine the effi cacy of cryotherapy on patients under high-dose melphalan treatment. First, the eff ect of cryotherapy on the frequency and severity of oral mucositis is examined. Second, the eff ect of cryotherapy on the length of hospitalization and on the administration of analgesics, antibiotics, and nutritional supplements is evaluated. From October 2009 to September 2012, 97 patients with multiple myeloma scheduled to receive melphalan 200 mg/m2 were provied cryotherapy. Patients were instructed to continue this procedure 5 min before, 30 min during and for 30 min after the infusion of melphalan. The control group consists of patients who had received high-dose (200 mg/m 2 ) Melphalan treatment from October 2006 to September 2009. Apart from the cryotherapy, the two groups were otherwise similar. Upon comparison of the frequency of occurrence of oral mucositis, the experimental group exhibited signifi cantly lower incidences than the control group (p = 0.007). While only 13 patients (21.3%) in the control group did not develop oral mucositis, as many as 41 patients (42.3%) in the experimental group (p=0.001) did not. Among those who developed oral mucositis, 37 in the experimental group (38.2%) exhibited Grade 2 or above vs. 43 in the control group (70.5%). No patient developed oral mucositis of Grade 4 or higher in either group. Patients in pain due to oral mucositis received analgesics as follows: 34 in the experimental group (35.1%) who received cryotherapy vs. 44 in the control group (72.1%), showing a lower rate of pain killer usage in the experimental group (p=0.000). Antibiotics usage was less frequent in the experimental group: 31 patients (32.0%) did not receive antibiotics vs. 8 patients (13.1%) in the control group (p=0.007). The results of the study confi rm that cryotherapy reduces oral mucositis among high-dose Melphalan recipients. Furthermore, a signifi cant diff erence was observed in the frequency of incidence of oral mucositis and in the duration of analgesics administration. Cryotherapy reduces the risk of infection during high-dose Melphalan treatment of patients as well the patient's level of discomfort.
P1405
A simple tool to aid in the prevention of veno-occlusive disease D. Landery, K. Elison, S. Tang, M 
. Moses Childrens Hospital Los Angeles (Los Angeles, US)
Hematopoietic Stem Cell Transplant (HSCT) centers are growing in the United States as transplants are indicated for many diff erent medical conditions. Chemotherapy modalities are becoming more complex as HSCT teams have more chemotherapy and conditioning options for preparing patients for transplant. Unfortunately, complications for HSCT are on the rise. The objective of the HSCT team at Children's Hospital Los Angeles (CHLA) was to create a tool to better track a symptom of a common complication of transplant, Hepatic Veno-Occlusive Disease (VOD). The classic triad of symptoms is weight gain, painful hepatomegaly and jaundice. Due to rotating doctors and bedside nurses, medical orders of daily weights are not suffi cient;and treatment of VOD depends largely on prevention or early intervention. We created a tool that will measure and record weight gain in a way that any medical professional can follow easily. In the past year we have had several patients diagnosed with VOD. Their diseases range from Acute Myeloid Leukemia to Chronic Granulomatous Disease. The conditioning regimens vary from Busulfan-Melphalan-ATG to Fludaribine-Cytoxan-TBI; yet the symptoms of VOD do not vary. Weight gain of 5% needs early intervention. We have found that
[P1405]
S504 aggressive intervention results in better outcomes. By referring to our tool, the medical team is able to track the fi rst sign of weight gain and begin early intervention, most commonly by starting a diuretic such as aldactone. The next step of the intervention is to increase measurements of the patient's weight to twice a day. The bedside nurses record 12 hour and 24 hour weight changes on the tool. The outcomes of this tool and subsequent implementation were earlier and more consistent detection of weight gain aff ording us earlier intervention for potential VOD. This simple tool can alert the physician to start treatment at an earlier point;hopefully catching VOD before it progresses in severity. By having the admission weight visible next to the daily weight, it serves as a reminder of the baseline weight and trends the weight gain to allow for early detection of VOD and subsequent intervention.
P1406 Patient satisfaction under the context of transplantation T. Reis Barreiros IPOLFG (Lisbon, PT)
Continuous quality improvement in health services takes part of the processes in health care management and political programs. One of the most important indicators in assessing quality of health services is patient satisfaction. Measuring, evaluating and reporting on patient satisfaction within health care have become a priority for all medical and health managers in the last years. The purpose of this thesis is to study the patient satisfaction under the context of transplantation, specifi cally bone marrow transplantation in internment. This study took part in the Bone Marrow Transplant Unit of the Instituto Português de Oncologia Francisco Gentil de Lisboa (IPOLFG). Patient satisfaction is a broad concept within healthcare quality management. The literature review enabled the identifi cation, analysis and a better understanding of the patient satisfaction concept in oncology. Is a quantitative and descriptive-correlational study and was conducted with a sample of 35 cancer patients who where submit to bone marrow transplant in IPOLFG, selected according to the method of consecutive sampling (not probabilistic). The instrument of data collection used consisted of a questionnaire composed of questions relating to socio-demographic and clinical variables and the scale for the assessment of satisfaction with care received (PATSAT32). The results indicate that patients who were submitted to a bone marrow transplant are very satisfi ed with the health care available whilst interned in UTM of IPOLFG. Patients seemed to be more satisfi ed with the assistance of doctors and nurses and less satisfi ed with the organizational procedures.
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Nursing management to optimize the central vascular catheter medication process with the aim of minimizing infection risk L. Cappucciati, R. Maestri, C.F. Moroni, A. Lazzaro, M.T. Borsotti, V. Valenti, N. Bacchetta, M. Muroni, M.R. Cordani, G. Cremona, L. Cavanna, D. Vallisa Piacenza Hospital (Piacenza, IT) Background: Nowadays Central Venous Catheter (CVC) is widely used to administer long-term and high dose therapy especially in onco-hematologic patients, but the he use of this medical device increases the risk of bloodstream CVC-related infections and infection of the insertion point. Purpose of Review: Our fi rst aim was to involve both nurses and medical staff of our Department to follow all the CVC-related steps: placement, management and recording. All the passage are documented to help us to point out critical fi ndings, improve the staff behaviour in daily management and think about actions to reach high standards. The daily records are not only a key step but also an essential way to document a correct medical practise of CVC-team.
Methods: The CDC Guidelines (Atlanta 2011) are currently used as standard at our Department. During CVC placement medical staff records all data concerning: patient identifi cation, staff identifi cation, patient disease, CVC type, blood tests, number of steps and any complication at this point. Afterwards nurse team will be in charge of the recording concerning "the entire life of intravascular device". Moreover each medications is recorded in patient's card, including ECOG score of the insertion point, blood cultures test and any intolerance patch. The recording patient cards were created to collect all data to monitor the entire CVC-process. Table A Table B ). Actually our intent is to observe the CVC process and to evidence eventual critical step. Our goal will be to extend our recording accuracy to all Departments involved in CVC management and create a common data-base widely used in our Hospital to work all together to minimize the infection risk.
